date generated: 2023-08-29
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
0610009B22Rik | 1.8312366 |
0610009E02Rik | -0.1037028 |
0610009L18Rik | -0.0756377 |
0610010K14Rik | 0.4176706 |
0610012G03Rik | 0.0087096 |
0610030E20Rik | -1.6095238 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 16611 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8254 |
num_profile_genes_not_in_sets | 8357 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmtGene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 437 |
num_genesets_included | 1167 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 1.76e-04 | 0.653 | 1.66e-03 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 5.35e-04 | 0.555 | 4.39e-03 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 4.07e-05 | 0.544 | 5.10e-04 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 3.02e-03 | 0.542 | 1.72e-02 |
COMPLEX I BIOGENESIS | 56 | 4.20e-12 | 0.535 | 2.88e-10 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 3.51e-05 | 0.534 | 4.55e-04 |
TRIGLYCERIDE CATABOLISM | 14 | 6.68e-04 | 0.525 | 5.32e-03 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 2.44e-05 | 0.520 | 3.35e-04 |
FRS MEDIATED FGFR4 SIGNALING | 12 | 1.92e-03 | 0.517 | 1.22e-02 |
SHC MEDIATED CASCADE FGFR4 | 10 | 4.74e-03 | 0.516 | 2.44e-02 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.06e-16 | 0.514 | 1.12e-14 |
CRMPS IN SEMA3A SIGNALING | 16 | 3.87e-04 | -0.512 | 3.32e-03 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 4.50e-19 | 0.511 | 8.75e-17 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 3.54e-05 | 0.509 | 4.55e-04 |
PI 3K CASCADE FGFR4 | 10 | 5.34e-03 | 0.509 | 2.65e-02 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.14e-22 | 0.504 | 5.00e-20 |
PLATELET SENSITIZATION BY LDL | 15 | 7.66e-04 | 0.502 | 5.80e-03 |
FRS MEDIATED FGFR3 SIGNALING | 14 | 1.21e-03 | 0.500 | 8.22e-03 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 6.28e-03 | 0.499 | 3.03e-02 |
SHC MEDIATED CASCADE FGFR3 | 12 | 2.96e-03 | 0.496 | 1.69e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 4.08e-06 | 0.494 | 8.50e-05 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 2.06e-03 | 0.494 | 1.29e-02 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 2.77e-18 | 0.490 | 3.59e-16 |
PI 3K CASCADE FGFR3 | 12 | 3.31e-03 | 0.490 | 1.82e-02 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 15 | 1.13e-03 | 0.486 | 7.83e-03 |
RHOBTB3 ATPASE CYCLE | 10 | 8.05e-03 | 0.484 | 3.70e-02 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 3.84e-04 | 0.483 | 3.32e-03 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.91e-10 | 0.479 | 1.01e-08 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 9.08e-03 | 0.476 | 4.11e-02 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 3.15e-06 | 0.476 | 6.80e-05 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 17 | 7.16e-04 | 0.474 | 5.57e-03 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 2.33e-18 | 0.474 | 3.40e-16 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 1.05e-03 | 0.473 | 7.50e-03 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 4.71e-03 | 0.471 | 2.43e-02 |
RAS PROCESSING | 23 | 9.45e-05 | 0.470 | 9.89e-04 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.15e-26 | 0.470 | 8.35e-24 |
GLYCOGEN SYNTHESIS | 14 | 2.42e-03 | 0.468 | 1.45e-02 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 4.97e-15 | 0.467 | 4.46e-13 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 1.97e-03 | 0.462 | 1.24e-02 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 7.75e-04 | 0.458 | 5.80e-03 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 1.23e-02 | 0.457 | 5.23e-02 |
GLYCOGEN STORAGE DISEASES | 12 | 6.47e-03 | 0.454 | 3.11e-02 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 4.42e-04 | 0.454 | 3.68e-03 |
PROTEIN METHYLATION | 17 | 1.24e-03 | 0.452 | 8.39e-03 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 6.93e-03 | 0.450 | 3.26e-02 |
ENOS ACTIVATION | 11 | 1.00e-02 | 0.448 | 4.44e-02 |
DARPP 32 EVENTS | 23 | 2.28e-04 | 0.444 | 2.08e-03 |
MITOPHAGY | 29 | 5.75e-05 | 0.432 | 6.65e-04 |
CRISTAE FORMATION | 31 | 3.33e-05 | 0.431 | 4.46e-04 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 7.20e-03 | 0.430 | 3.35e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 1.76e-04 | 6.53e-01 | 1.66e-03 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 5.35e-04 | 5.55e-01 | 4.39e-03 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 4.07e-05 | 5.44e-01 | 5.10e-04 |
ASPARTATE AND ASPARAGINE METABOLISM | 10 | 3.02e-03 | 5.42e-01 | 1.72e-02 |
COMPLEX I BIOGENESIS | 56 | 4.20e-12 | 5.35e-01 | 2.88e-10 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 3.51e-05 | 5.34e-01 | 4.55e-04 |
TRIGLYCERIDE CATABOLISM | 14 | 6.68e-04 | 5.25e-01 | 5.32e-03 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 2.44e-05 | 5.20e-01 | 3.35e-04 |
FRS MEDIATED FGFR4 SIGNALING | 12 | 1.92e-03 | 5.17e-01 | 1.22e-02 |
SHC MEDIATED CASCADE FGFR4 | 10 | 4.74e-03 | 5.16e-01 | 2.44e-02 |
EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.06e-16 | 5.14e-01 | 1.12e-14 |
CRMPS IN SEMA3A SIGNALING | 16 | 3.87e-04 | -5.12e-01 | 3.32e-03 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 4.50e-19 | 5.11e-01 | 8.75e-17 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 3.54e-05 | 5.09e-01 | 4.55e-04 |
PI 3K CASCADE FGFR4 | 10 | 5.34e-03 | 5.09e-01 | 2.65e-02 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 2.14e-22 | 5.04e-01 | 5.00e-20 |
PLATELET SENSITIZATION BY LDL | 15 | 7.66e-04 | 5.02e-01 | 5.80e-03 |
FRS MEDIATED FGFR3 SIGNALING | 14 | 1.21e-03 | 5.00e-01 | 8.22e-03 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 6.28e-03 | 4.99e-01 | 3.03e-02 |
SHC MEDIATED CASCADE FGFR3 | 12 | 2.96e-03 | 4.96e-01 | 1.69e-02 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 4.08e-06 | 4.94e-01 | 8.50e-05 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 2.06e-03 | 4.94e-01 | 1.29e-02 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 2.77e-18 | 4.90e-01 | 3.59e-16 |
PI 3K CASCADE FGFR3 | 12 | 3.31e-03 | 4.90e-01 | 1.82e-02 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 15 | 1.13e-03 | 4.86e-01 | 7.83e-03 |
RHOBTB3 ATPASE CYCLE | 10 | 8.05e-03 | 4.84e-01 | 3.70e-02 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 3.84e-04 | 4.83e-01 | 3.32e-03 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.91e-10 | 4.79e-01 | 1.01e-08 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 9.08e-03 | 4.76e-01 | 4.11e-02 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 3.15e-06 | 4.76e-01 | 6.80e-05 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 17 | 7.16e-04 | 4.74e-01 | 5.57e-03 |
EUKARYOTIC TRANSLATION INITIATION | 114 | 2.33e-18 | 4.74e-01 | 3.40e-16 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 1.05e-03 | 4.73e-01 | 7.50e-03 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 4.71e-03 | 4.71e-01 | 2.43e-02 |
RAS PROCESSING | 23 | 9.45e-05 | 4.70e-01 | 9.89e-04 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.15e-26 | 4.70e-01 | 8.35e-24 |
GLYCOGEN SYNTHESIS | 14 | 2.42e-03 | 4.68e-01 | 1.45e-02 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 4.97e-15 | 4.67e-01 | 4.46e-13 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 1.97e-03 | 4.62e-01 | 1.24e-02 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 7.75e-04 | 4.58e-01 | 5.80e-03 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 1.23e-02 | 4.57e-01 | 5.23e-02 |
GLYCOGEN STORAGE DISEASES | 12 | 6.47e-03 | 4.54e-01 | 3.11e-02 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 4.42e-04 | 4.54e-01 | 3.68e-03 |
PROTEIN METHYLATION | 17 | 1.24e-03 | 4.52e-01 | 8.39e-03 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 6.93e-03 | 4.50e-01 | 3.26e-02 |
ENOS ACTIVATION | 11 | 1.00e-02 | 4.48e-01 | 4.44e-02 |
DARPP 32 EVENTS | 23 | 2.28e-04 | 4.44e-01 | 2.08e-03 |
MITOPHAGY | 29 | 5.75e-05 | 4.32e-01 | 6.65e-04 |
CRISTAE FORMATION | 31 | 3.33e-05 | 4.31e-01 | 4.46e-04 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 7.20e-03 | 4.30e-01 | 3.35e-02 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 1.49e-02 | 4.24e-01 | 6.12e-02 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 1.10e-02 | 4.24e-01 | 4.76e-02 |
SIGNAL AMPLIFICATION | 30 | 6.37e-05 | 4.22e-01 | 7.22e-04 |
SELENOAMINO ACID METABOLISM | 107 | 8.65e-14 | 4.17e-01 | 6.73e-12 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 1.35e-02 | 4.12e-01 | 5.66e-02 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 8.32e-04 | 4.12e-01 | 6.10e-03 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 1.11e-03 | 4.11e-01 | 7.79e-03 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 7.80e-05 | 4.10e-01 | 8.35e-04 |
CTLA4 INHIBITORY SIGNALING | 19 | 2.04e-03 | 4.09e-01 | 1.28e-02 |
CD28 DEPENDENT VAV1 PATHWAY | 10 | 2.57e-02 | 4.07e-01 | 8.98e-02 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.26e-03 | 4.06e-01 | 8.43e-03 |
CALNEXIN CALRETICULIN CYCLE | 26 | 3.51e-04 | 4.05e-01 | 3.08e-03 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 2.66e-02 | 4.05e-01 | 9.20e-02 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 17 | 3.96e-03 | 4.04e-01 | 2.11e-02 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 19 | 2.37e-03 | 4.03e-01 | 1.43e-02 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 9.77e-08 | 4.01e-01 | 3.26e-06 |
METABOLISM OF POLYAMINES | 57 | 1.88e-07 | 3.99e-01 | 5.62e-06 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 7.52e-03 | 3.99e-01 | 3.48e-02 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 7.34e-04 | 3.98e-01 | 5.64e-03 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 9.01e-07 | 3.98e-01 | 2.45e-05 |
GAP JUNCTION DEGRADATION | 11 | 2.44e-02 | 3.92e-01 | 8.76e-02 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 6.35e-05 | 3.91e-01 | 7.22e-04 |
COMPLEMENT CASCADE | 22 | 1.52e-03 | 3.91e-01 | 9.95e-03 |
TRP CHANNELS | 19 | 3.30e-03 | -3.89e-01 | 1.82e-02 |
GLUTATHIONE CONJUGATION | 29 | 2.88e-04 | 3.89e-01 | 2.58e-03 |
GLYCOGEN METABOLISM | 25 | 7.73e-04 | 3.88e-01 | 5.80e-03 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 5.38e-06 | 3.88e-01 | 9.66e-05 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 5.84e-03 | -3.86e-01 | 2.84e-02 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 24 | 1.13e-03 | 3.84e-01 | 7.83e-03 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.30e-06 | 3.81e-01 | 3.15e-05 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 9.98e-05 | 3.80e-01 | 1.03e-03 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 1.78e-02 | 3.80e-01 | 7.00e-02 |
TRANSLATION | 286 | 2.36e-28 | 3.80e-01 | 1.38e-25 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.89e-02 | 3.76e-01 | 7.31e-02 |
GLUCONEOGENESIS | 27 | 7.84e-04 | 3.73e-01 | 5.82e-03 |
MITOCHONDRIAL TRANSLATION | 93 | 4.88e-10 | 3.73e-01 | 2.28e-08 |
NONSENSE MEDIATED DECAY NMD | 109 | 2.12e-11 | 3.71e-01 | 1.30e-09 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 1.03e-02 | 3.70e-01 | 4.50e-02 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 307 | 7.70e-29 | 3.70e-01 | 8.99e-26 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 160 | 7.02e-16 | 3.70e-01 | 6.83e-14 |
METHYLATION | 11 | 3.49e-02 | 3.67e-01 | 1.11e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 3.83e-06 | 3.67e-01 | 8.12e-05 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.54e-02 | 3.66e-01 | 1.11e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 4.32e-06 | 3.65e-01 | 8.69e-05 |
INSULIN RECEPTOR RECYCLING | 20 | 4.85e-03 | 3.64e-01 | 2.45e-02 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 2.53e-03 | 3.64e-01 | 1.50e-02 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 2.34e-02 | 3.63e-01 | 8.50e-02 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 2.28e-06 | 3.62e-01 | 5.13e-05 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 8.84e-07 | 3.58e-01 | 2.45e-05 |
FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 3.18e-02 | 3.58e-01 | 1.03e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 4.02e-02 | 3.57e-01 | 1.23e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 4.04e-02 | 3.57e-01 | 1.23e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 2.59e-02 | 3.57e-01 | 9.03e-02 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 12 | 3.27e-02 | 3.56e-01 | 1.06e-01 |
TRIGLYCERIDE METABOLISM | 22 | 3.86e-03 | 3.56e-01 | 2.08e-02 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 1.54e-06 | 3.56e-01 | 3.68e-05 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 3.35e-02 | 3.55e-01 | 1.07e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 6.89e-08 | 3.53e-01 | 2.59e-06 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 3.50e-03 | 3.52e-01 | 1.91e-02 |
FRS MEDIATED FGFR2 SIGNALING | 18 | 1.01e-02 | 3.50e-01 | 4.46e-02 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 3.57e-02 | 3.50e-01 | 1.11e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 1.36e-05 | 3.49e-01 | 2.11e-04 |
CELLULAR RESPONSE TO STARVATION | 145 | 5.04e-13 | 3.48e-01 | 3.68e-11 |
PYRUVATE METABOLISM | 27 | 1.78e-03 | 3.48e-01 | 1.15e-02 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 4.64e-02 | 3.47e-01 | 1.37e-01 |
STABILIZATION OF P53 | 54 | 1.07e-05 | 3.46e-01 | 1.74e-04 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 2.21e-06 | 3.45e-01 | 5.05e-05 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 3.17e-02 | 3.44e-01 | 1.03e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 4.89e-02 | 3.43e-01 | 1.41e-01 |
COLLAGEN CHAIN TRIMERIZATION | 39 | 2.28e-04 | -3.41e-01 | 2.08e-03 |
DEGRADATION OF AXIN | 53 | 1.75e-05 | 3.41e-01 | 2.60e-04 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 5.02e-02 | 3.41e-01 | 1.44e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 6.96e-03 | 3.40e-01 | 3.26e-02 |
PENTOSE PHOSPHATE PATHWAY | 13 | 3.56e-02 | 3.37e-01 | 1.11e-01 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 7.85e-06 | 3.36e-01 | 1.37e-04 |
INITIAL TRIGGERING OF COMPLEMENT | 10 | 6.56e-02 | 3.36e-01 | 1.78e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 28 | 2.09e-03 | 3.36e-01 | 1.29e-02 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 1.59e-07 | 3.35e-01 | 5.02e-06 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.51e-02 | 3.34e-01 | 1.34e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 1.05e-05 | 3.32e-01 | 1.73e-04 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 5.77e-02 | 3.31e-01 | 1.59e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 2.28e-02 | 3.29e-01 | 8.36e-02 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 6.50e-04 | 3.28e-01 | 5.26e-03 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 2.80e-02 | 3.28e-01 | 9.54e-02 |
KILLING MECHANISMS | 10 | 7.30e-02 | -3.27e-01 | 1.92e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 2.29e-03 | -3.27e-01 | 1.39e-02 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 11 | 6.04e-02 | 3.27e-01 | 1.66e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 36 | 7.21e-04 | -3.26e-01 | 5.58e-03 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 4.92e-06 | 3.25e-01 | 9.19e-05 |
FCERI MEDIATED NF KB ACTIVATION | 76 | 9.98e-07 | 3.25e-01 | 2.53e-05 |
PI 3K CASCADE FGFR2 | 16 | 2.49e-02 | 3.24e-01 | 8.76e-02 |
CELLULAR RESPONSE TO HYPOXIA | 71 | 2.45e-06 | 3.24e-01 | 5.39e-05 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 1.05e-02 | 3.23e-01 | 4.58e-02 |
PKMTS METHYLATE HISTONE LYSINES | 48 | 1.18e-04 | -3.21e-01 | 1.16e-03 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 1.85e-02 | 3.21e-01 | 7.24e-02 |
PHASE II CONJUGATION OF COMPOUNDS | 60 | 1.79e-05 | 3.20e-01 | 2.61e-04 |
ANTIGEN PROCESSING CROSS PRESENTATION | 93 | 9.55e-08 | 3.20e-01 | 3.26e-06 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 4.77e-03 | 3.20e-01 | 2.44e-02 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 1.94e-02 | 3.18e-01 | 7.41e-02 |
LDL CLEARANCE | 16 | 2.78e-02 | 3.18e-01 | 9.51e-02 |
PROTEIN UBIQUITINATION | 69 | 5.11e-06 | 3.18e-01 | 9.31e-05 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 3.38e-02 | 3.16e-01 | 1.08e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 1.23e-02 | 3.16e-01 | 5.23e-02 |
TIE2 SIGNALING | 17 | 2.46e-02 | 3.15e-01 | 8.76e-02 |
G PROTEIN ACTIVATION | 22 | 1.07e-02 | 3.14e-01 | 4.66e-02 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 8.54e-02 | 3.14e-01 | 2.11e-01 |
PROTEIN LOCALIZATION | 156 | 1.41e-11 | 3.14e-01 | 9.14e-10 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 4.09e-03 | 3.14e-01 | 2.16e-02 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.20e-02 | -3.13e-01 | 1.90e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 4.86e-03 | 3.13e-01 | 2.45e-02 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 5.25e-04 | 3.13e-01 | 4.35e-03 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 3.18e-03 | 3.11e-01 | 1.78e-02 |
INFLAMMASOMES | 19 | 1.90e-02 | 3.11e-01 | 7.31e-02 |
NUCLEOBASE BIOSYNTHESIS | 15 | 3.71e-02 | 3.11e-01 | 1.15e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 8.88e-02 | 3.11e-01 | 2.17e-01 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 1.38e-02 | -3.11e-01 | 5.72e-02 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 23 | 1.00e-02 | 3.10e-01 | 4.44e-02 |
ANCHORING FIBRIL FORMATION | 13 | 5.33e-02 | -3.10e-01 | 1.50e-01 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 1.48e-05 | 3.08e-01 | 2.25e-04 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 4.63e-02 | 3.08e-01 | 1.37e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 9.24e-02 | -3.07e-01 | 2.24e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 1.26e-02 | 3.07e-01 | 5.33e-02 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 2.09e-02 | 3.06e-01 | 7.75e-02 |
FATTY ACID METABOLISM | 146 | 1.73e-10 | 3.06e-01 | 9.63e-09 |
IRAK4 DEFICIENCY TLR2 4 | 12 | 6.64e-02 | 3.06e-01 | 1.79e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 9.23e-08 | 3.05e-01 | 3.26e-06 |
INFLUENZA INFECTION | 145 | 2.48e-10 | 3.05e-01 | 1.26e-08 |
DEGRADATION OF DVL | 55 | 9.49e-05 | 3.04e-01 | 9.89e-04 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 2.59e-03 | 3.03e-01 | 1.53e-02 |
SIGNALING BY ROBO RECEPTORS | 205 | 8.18e-14 | 3.03e-01 | 6.73e-12 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 1.20e-02 | 3.03e-01 | 5.15e-02 |
SIGNALING BY FGFR4 | 31 | 3.57e-03 | 3.02e-01 | 1.94e-02 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 21 | 1.65e-02 | 3.02e-01 | 6.62e-02 |
RHOBTB2 GTPASE CYCLE | 23 | 1.24e-02 | 3.01e-01 | 5.25e-02 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 8.47e-02 | 3.00e-01 | 2.11e-01 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 2.32e-05 | 2.99e-01 | 3.23e-04 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 3.98e-03 | 2.99e-01 | 2.11e-02 |
FRS MEDIATED FGFR1 SIGNALING | 17 | 3.31e-02 | 2.99e-01 | 1.07e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 3.81e-05 | 2.98e-01 | 4.83e-04 |
ABC TRANSPORTER DISORDERS | 69 | 1.95e-05 | 2.97e-01 | 2.78e-04 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 8.89e-02 | -2.96e-01 | 2.17e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 32 | 3.83e-03 | 2.95e-01 | 2.07e-02 |
SULFUR AMINO ACID METABOLISM | 22 | 1.66e-02 | 2.95e-01 | 6.62e-02 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 5.70e-02 | 2.94e-01 | 1.58e-01 |
SEROTONIN RECEPTORS | 10 | 1.09e-01 | 2.93e-01 | 2.50e-01 |
AQUAPORIN MEDIATED TRANSPORT | 40 | 1.37e-03 | 2.93e-01 | 9.08e-03 |
CLEC7A DECTIN 1 SIGNALING | 94 | 9.62e-07 | 2.92e-01 | 2.49e-05 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 69 | 2.90e-05 | 2.91e-01 | 3.93e-04 |
SARS COV 2 INFECTION | 65 | 4.96e-05 | 2.91e-01 | 6.03e-04 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 6.69e-03 | 2.91e-01 | 3.19e-02 |
SCAVENGING BY CLASS A RECEPTORS | 13 | 6.96e-02 | 2.91e-01 | 1.86e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 4.19e-06 | 2.91e-01 | 8.58e-05 |
CHAPERONE MEDIATED AUTOPHAGY | 20 | 2.48e-02 | 2.90e-01 | 8.76e-02 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 6.00e-03 | -2.90e-01 | 2.91e-02 |
LYSOSOME VESICLE BIOGENESIS | 33 | 3.98e-03 | 2.90e-01 | 2.11e-02 |
C TYPE LECTIN RECEPTORS CLRS | 111 | 1.40e-07 | 2.89e-01 | 4.53e-06 |
ANTIMICROBIAL PEPTIDES | 14 | 6.09e-02 | 2.89e-01 | 1.67e-01 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.65e-02 | 2.89e-01 | 6.62e-02 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 1.08e-02 | 2.89e-01 | 4.66e-02 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 3.42e-05 | 2.89e-01 | 4.54e-04 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 2.47e-03 | 2.88e-01 | 1.47e-02 |
BIOLOGICAL OXIDATIONS | 123 | 3.92e-08 | 2.87e-01 | 1.53e-06 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 8.55e-02 | 2.87e-01 | 2.11e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 3.54e-02 | -2.86e-01 | 1.11e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 1.17e-01 | 2.86e-01 | 2.65e-01 |
MET RECEPTOR RECYCLING | 10 | 1.18e-01 | 2.86e-01 | 2.65e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 1.02e-01 | 2.85e-01 | 2.39e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 7.62e-05 | 2.84e-01 | 8.31e-04 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 5.52e-03 | 2.83e-01 | 2.71e-02 |
PYROPTOSIS | 20 | 2.91e-02 | 2.82e-01 | 9.80e-02 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 1.23e-01 | -2.82e-01 | 2.74e-01 |
REGULATION OF RAS BY GAPS | 66 | 7.79e-05 | 2.81e-01 | 8.35e-04 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 7.92e-02 | 2.81e-01 | 2.01e-01 |
RAF ACTIVATION | 34 | 4.85e-03 | 2.79e-01 | 2.45e-02 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 50 | 6.55e-04 | 2.79e-01 | 5.27e-03 |
SIGNALING BY FGFR3 | 34 | 5.07e-03 | 2.78e-01 | 2.55e-02 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 1.43e-02 | 2.77e-01 | 5.91e-02 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 8.38e-02 | 2.77e-01 | 2.10e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 1.12e-01 | 2.77e-01 | 2.55e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 93 | 4.96e-06 | 2.74e-01 | 9.19e-05 |
RHO GTPASES ACTIVATE KTN1 | 11 | 1.16e-01 | 2.74e-01 | 2.63e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 1.16e-01 | 2.73e-01 | 2.64e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 123 | 1.72e-07 | 2.73e-01 | 5.28e-06 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 149 | 9.49e-09 | 2.73e-01 | 4.10e-07 |
INTERLEUKIN 12 SIGNALING | 37 | 4.39e-03 | 2.71e-01 | 2.28e-02 |
SPHINGOLIPID METABOLISM | 79 | 3.54e-05 | 2.69e-01 | 4.55e-04 |
SIGNALING BY RETINOIC ACID | 32 | 8.61e-03 | 2.68e-01 | 3.94e-02 |
SHC MEDIATED CASCADE FGFR1 | 15 | 7.20e-02 | 2.68e-01 | 1.90e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 1.43e-02 | -2.67e-01 | 5.91e-02 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 107 | 1.79e-06 | 2.67e-01 | 4.18e-05 |
TNFR2 NON CANONICAL NF KB PATHWAY | 79 | 4.14e-05 | 2.67e-01 | 5.14e-04 |
CS DS DEGRADATION | 14 | 8.45e-02 | 2.66e-01 | 2.11e-01 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 4.51e-02 | 2.66e-01 | 1.34e-01 |
SARS COV 1 INFECTION | 48 | 1.48e-03 | 2.65e-01 | 9.77e-03 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 9.44e-03 | -2.65e-01 | 4.22e-02 |
INTERLEUKIN 1 SIGNALING | 95 | 8.20e-06 | 2.65e-01 | 1.41e-04 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 2.81e-02 | 2.65e-01 | 9.54e-02 |
PI 3K CASCADE FGFR1 | 15 | 7.71e-02 | 2.64e-01 | 1.98e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 7.77e-02 | 2.63e-01 | 1.99e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 23 | 2.94e-02 | 2.62e-01 | 9.89e-02 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 2.32e-02 | 2.62e-01 | 8.46e-02 |
DNA REPLICATION PRE INITIATION | 79 | 5.68e-05 | 2.62e-01 | 6.65e-04 |
CROSSLINKING OF COLLAGEN FIBRILS | 13 | 1.03e-01 | -2.61e-01 | 2.41e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 3.80e-04 | 2.61e-01 | 3.31e-03 |
RRNA PROCESSING | 194 | 3.88e-10 | 2.61e-01 | 1.89e-08 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 1.52e-02 | 2.61e-01 | 6.20e-02 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 80 | 5.75e-05 | 2.60e-01 | 6.65e-04 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 1.67e-04 | 2.60e-01 | 1.59e-03 |
INTERLEUKIN 12 FAMILY SIGNALING | 44 | 2.87e-03 | 2.60e-01 | 1.65e-02 |
NEUTROPHIL DEGRANULATION | 384 | 3.13e-18 | 2.59e-01 | 3.66e-16 |
FCERI MEDIATED CA 2 MOBILIZATION | 26 | 2.21e-02 | 2.59e-01 | 8.15e-02 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 21 | 3.98e-02 | 2.59e-01 | 1.22e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 1.06e-01 | 2.59e-01 | 2.47e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 1.21e-01 | 2.58e-01 | 2.71e-01 |
PEROXISOMAL LIPID METABOLISM | 26 | 2.28e-02 | 2.58e-01 | 8.36e-02 |
PURINE CATABOLISM | 16 | 7.49e-02 | 2.57e-01 | 1.95e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.65e-02 | 2.57e-01 | 6.62e-02 |
TCR SIGNALING | 101 | 8.31e-06 | 2.57e-01 | 1.41e-04 |
SIGNALING BY BMP | 24 | 2.95e-02 | 2.57e-01 | 9.89e-02 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 2.17e-02 | 2.55e-01 | 8.00e-02 |
SIGNALING BY NOTCH4 | 83 | 6.46e-05 | 2.54e-01 | 7.25e-04 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 2.06e-02 | 2.53e-01 | 7.68e-02 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 4.50e-02 | 2.53e-01 | 1.34e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 30 | 1.66e-02 | 2.53e-01 | 6.62e-02 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 2.60e-02 | 2.52e-01 | 9.04e-02 |
SIGNALING BY INSULIN RECEPTOR | 61 | 6.70e-04 | 2.52e-01 | 5.32e-03 |
KINESINS | 47 | 2.83e-03 | -2.52e-01 | 1.64e-02 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 3.52e-02 | 2.48e-01 | 1.11e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 89 | 5.21e-05 | 2.48e-01 | 6.26e-04 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 81 | 1.18e-04 | 2.48e-01 | 1.16e-03 |
ARACHIDONIC ACID METABOLISM | 40 | 6.78e-03 | 2.47e-01 | 3.21e-02 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 7.75e-02 | -2.47e-01 | 1.99e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 4.04e-02 | -2.47e-01 | 1.23e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 1.24e-01 | 2.47e-01 | 2.76e-01 |
NCAM1 INTERACTIONS | 39 | 7.86e-03 | -2.46e-01 | 3.62e-02 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 62 | 8.42e-04 | -2.45e-01 | 6.14e-03 |
PYRIMIDINE SALVAGE | 10 | 1.80e-01 | -2.45e-01 | 3.56e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 11 | 1.60e-01 | 2.44e-01 | 3.27e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 3.11e-02 | 2.44e-01 | 1.02e-01 |
MET ACTIVATES RAP1 AND RAC1 | 11 | 1.61e-01 | 2.44e-01 | 3.28e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 5.97e-02 | 2.43e-01 | 1.64e-01 |
METABOLISM OF COFACTORS | 18 | 7.41e-02 | 2.43e-01 | 1.94e-01 |
INWARDLY RECTIFYING K CHANNELS | 31 | 1.97e-02 | 2.42e-01 | 7.53e-02 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 1.86e-01 | -2.42e-01 | 3.64e-01 |
SIGNALING BY CSF3 G CSF | 29 | 2.44e-02 | 2.41e-01 | 8.76e-02 |
CYTOPROTECTION BY HMOX1 | 119 | 5.68e-06 | 2.41e-01 | 1.00e-04 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 1.22e-04 | 2.40e-01 | 1.19e-03 |
GLUCAGON TYPE LIGAND RECEPTORS | 23 | 4.68e-02 | 2.39e-01 | 1.38e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 3.20e-02 | 2.39e-01 | 1.04e-01 |
MAPK6 MAPK4 SIGNALING | 83 | 1.82e-04 | 2.38e-01 | 1.70e-03 |
HOST INTERACTIONS OF HIV FACTORS | 125 | 4.80e-06 | 2.37e-01 | 9.19e-05 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 1.01e-01 | 2.37e-01 | 2.39e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 225 | 9.53e-10 | 2.37e-01 | 4.28e-08 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 60 | 1.72e-03 | 2.34e-01 | 1.12e-02 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 5.80e-02 | 2.34e-01 | 1.60e-01 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 9.58e-02 | 2.33e-01 | 2.31e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 1.31e-01 | 2.33e-01 | 2.85e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 9.70e-04 | 2.33e-01 | 7.03e-03 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 23 | 5.38e-02 | 2.32e-01 | 1.51e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 16 | 1.08e-01 | 2.32e-01 | 2.48e-01 |
PEXOPHAGY | 11 | 1.83e-01 | 2.32e-01 | 3.61e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 3.19e-03 | 2.30e-01 | 1.78e-02 |
S PHASE | 153 | 9.39e-07 | 2.30e-01 | 2.49e-05 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 1.53e-01 | -2.29e-01 | 3.18e-01 |
METALLOPROTEASE DUBS | 25 | 4.77e-02 | 2.29e-01 | 1.39e-01 |
DAP12 INTERACTIONS | 29 | 3.32e-02 | 2.28e-01 | 1.07e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 123 | 1.27e-05 | 2.28e-01 | 2.03e-04 |
METABOLISM OF PORPHYRINS | 19 | 8.58e-02 | 2.28e-01 | 2.11e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 7.94e-02 | 2.27e-01 | 2.01e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 14 | 1.43e-01 | 2.26e-01 | 3.03e-01 |
EPHRIN SIGNALING | 19 | 8.78e-02 | 2.26e-01 | 2.16e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 11 | 1.97e-01 | 2.25e-01 | 3.76e-01 |
FORMATION OF APOPTOSOME | 10 | 2.19e-01 | 2.25e-01 | 3.95e-01 |
RAB GERANYLGERANYLATION | 58 | 3.16e-03 | 2.24e-01 | 1.78e-02 |
PEROXISOMAL PROTEIN IMPORT | 57 | 3.45e-03 | 2.24e-01 | 1.89e-02 |
SIGNALING BY FGFR1 | 43 | 1.11e-02 | 2.24e-01 | 4.77e-02 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 51 | 5.82e-03 | -2.23e-01 | 2.84e-02 |
PHASE 0 RAPID DEPOLARISATION | 31 | 3.15e-02 | -2.23e-01 | 1.03e-01 |
LGI ADAM INTERACTIONS | 14 | 1.49e-01 | -2.23e-01 | 3.12e-01 |
GABA RECEPTOR ACTIVATION | 52 | 5.51e-03 | 2.23e-01 | 2.71e-02 |
RHO GTPASES ACTIVATE CIT | 18 | 1.03e-01 | 2.22e-01 | 2.41e-01 |
GABA B RECEPTOR ACTIVATION | 39 | 1.65e-02 | 2.22e-01 | 6.62e-02 |
N GLYCAN ANTENNAE ELONGATION | 15 | 1.37e-01 | 2.22e-01 | 2.94e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 1.86e-02 | 2.21e-01 | 7.27e-02 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 2.06e-01 | 2.20e-01 | 3.82e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 2.28e-01 | 2.20e-01 | 4.06e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 1.88e-01 | 2.20e-01 | 3.65e-01 |
INNATE IMMUNE SYSTEM | 772 | 7.24e-25 | 2.19e-01 | 2.11e-22 |
THE NLRP3 INFLAMMASOME | 15 | 1.43e-01 | 2.18e-01 | 3.03e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 9.96e-02 | 2.18e-01 | 2.37e-01 |
COSTIMULATION BY THE CD28 FAMILY | 48 | 9.05e-03 | 2.18e-01 | 4.11e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 3.10e-04 | 2.18e-01 | 2.76e-03 |
PARASITE INFECTION | 55 | 5.30e-03 | 2.17e-01 | 2.64e-02 |
SYNDECAN INTERACTIONS | 26 | 5.55e-02 | 2.17e-01 | 1.56e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 3.12e-02 | 2.17e-01 | 1.02e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 1.76e-01 | 2.17e-01 | 3.52e-01 |
SIGNALING BY FGFR2 IN DISEASE | 36 | 2.45e-02 | 2.17e-01 | 8.76e-02 |
COHESIN LOADING ONTO CHROMATIN | 10 | 2.36e-01 | 2.16e-01 | 4.16e-01 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 2.36e-01 | 2.16e-01 | 4.16e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 5.02e-02 | 2.14e-01 | 1.44e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 1.07e-01 | 2.13e-01 | 2.48e-01 |
INTRAFLAGELLAR TRANSPORT | 49 | 9.76e-03 | -2.13e-01 | 4.35e-02 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 1.18e-01 | 2.13e-01 | 2.65e-01 |
BILE ACID AND BILE SALT METABOLISM | 24 | 7.14e-02 | 2.13e-01 | 1.90e-01 |
SMOOTH MUSCLE CONTRACTION | 33 | 3.49e-02 | 2.12e-01 | 1.11e-01 |
CD209 DC SIGN SIGNALING | 18 | 1.19e-01 | 2.12e-01 | 2.68e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 2.04e-01 | 2.12e-01 | 3.80e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 1.01e-01 | 2.12e-01 | 2.39e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 2.25e-01 | 2.11e-01 | 4.04e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 2.45e-02 | 2.11e-01 | 8.76e-02 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 1.44e-01 | 2.11e-01 | 3.05e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 140 | 1.86e-05 | 2.10e-01 | 2.68e-04 |
IRS MEDIATED SIGNALLING | 37 | 2.77e-02 | 2.09e-01 | 9.49e-02 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 7.68e-02 | 2.09e-01 | 1.98e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 5.67e-02 | 2.08e-01 | 1.58e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 2.13e-01 | 2.08e-01 | 3.89e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 1.02e-02 | 2.06e-01 | 4.49e-02 |
FOXO MEDIATED TRANSCRIPTION | 59 | 6.50e-03 | 2.05e-01 | 3.11e-02 |
ERKS ARE INACTIVATED | 13 | 2.02e-01 | 2.04e-01 | 3.79e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 2.22e-01 | 2.04e-01 | 4.00e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 9.84e-02 | 2.04e-01 | 2.35e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 2.44e-01 | 2.03e-01 | 4.21e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 5.89e-02 | 2.03e-01 | 1.62e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 2.01e-02 | 2.03e-01 | 7.56e-02 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 1.77e-01 | -2.02e-01 | 3.52e-01 |
OPIOID SIGNALLING | 86 | 1.26e-03 | 2.01e-01 | 8.43e-03 |
PLASMA LIPOPROTEIN CLEARANCE | 26 | 7.59e-02 | 2.01e-01 | 1.97e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 1.65e-03 | 2.01e-01 | 1.08e-02 |
FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 4.92e-02 | 2.01e-01 | 1.42e-01 |
SIGNALING BY WNT IN CANCER | 31 | 5.33e-02 | 2.01e-01 | 1.50e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 7.69e-02 | 2.00e-01 | 1.98e-01 |
REGULATED NECROSIS | 45 | 2.01e-02 | 2.00e-01 | 7.56e-02 |
DNA REPLICATION | 121 | 1.48e-04 | 2.00e-01 | 1.42e-03 |
PCP CE PATHWAY | 90 | 1.08e-03 | 1.99e-01 | 7.64e-03 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 9.82e-02 | 1.99e-01 | 2.35e-01 |
ACTIVATION OF SMO | 16 | 1.68e-01 | -1.99e-01 | 3.38e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 1.33e-01 | 1.99e-01 | 2.88e-01 |
RHOH GTPASE CYCLE | 37 | 3.63e-02 | 1.99e-01 | 1.13e-01 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 9.25e-02 | 1.98e-01 | 2.24e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 2.55e-01 | 1.98e-01 | 4.32e-01 |
DAP12 SIGNALING | 24 | 9.30e-02 | 1.98e-01 | 2.25e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 1.08e-01 | 1.98e-01 | 2.48e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 1.58e-01 | 1.98e-01 | 3.24e-01 |
PURINE SALVAGE | 12 | 2.36e-01 | 1.97e-01 | 4.16e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 13 | 2.18e-01 | -1.97e-01 | 3.95e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 9.47e-02 | 1.97e-01 | 2.29e-01 |
RHO GTPASES ACTIVATE PKNS | 47 | 1.99e-02 | 1.96e-01 | 7.53e-02 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 3.95e-04 | 1.96e-01 | 3.34e-03 |
HEDGEHOG ON STATE | 82 | 2.25e-03 | 1.95e-01 | 1.37e-02 |
SPRY REGULATION OF FGF SIGNALING | 16 | 1.77e-01 | 1.95e-01 | 3.52e-01 |
INFECTIOUS DISEASE | 727 | 1.02e-18 | 1.93e-01 | 1.70e-16 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 3.06e-02 | 1.93e-01 | 1.02e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 42 | 3.07e-02 | 1.93e-01 | 1.02e-01 |
PROLACTIN RECEPTOR SIGNALING | 11 | 2.69e-01 | 1.93e-01 | 4.46e-01 |
GAP JUNCTION ASSEMBLY | 21 | 1.27e-01 | 1.92e-01 | 2.80e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 1.05e-01 | 1.91e-01 | 2.46e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 3.04e-02 | -1.91e-01 | 1.01e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 1.76e-01 | -1.89e-01 | 3.52e-01 |
HEME SIGNALING | 44 | 2.98e-02 | -1.89e-01 | 9.97e-02 |
UCH PROTEINASES | 88 | 2.16e-03 | 1.89e-01 | 1.33e-02 |
TRANSLESION SYNTHESIS BY POLH | 19 | 1.53e-01 | 1.89e-01 | 3.18e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 2.05e-01 | 1.89e-01 | 3.81e-01 |
SARS COV INFECTIONS | 139 | 1.28e-04 | 1.88e-01 | 1.23e-03 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 88 | 2.37e-03 | 1.88e-01 | 1.43e-02 |
PHASE 2 PLATEAU PHASE | 13 | 2.42e-01 | -1.87e-01 | 4.18e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 2.82e-01 | -1.87e-01 | 4.60e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 10 | 3.06e-01 | -1.87e-01 | 4.83e-01 |
SIGNALING BY HIPPO | 20 | 1.48e-01 | 1.87e-01 | 3.10e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 3.12e-03 | 1.87e-01 | 1.77e-02 |
PROGRAMMED CELL DEATH | 185 | 1.29e-05 | 1.86e-01 | 2.03e-04 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 2.86e-01 | 1.86e-01 | 4.64e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 2.47e-01 | 1.86e-01 | 4.23e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 1.43e-01 | 1.85e-01 | 3.03e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 40 | 4.36e-02 | -1.84e-01 | 1.31e-01 |
ACTIVATION OF RAC1 | 13 | 2.50e-01 | 1.84e-01 | 4.28e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 77 | 5.36e-03 | 1.84e-01 | 2.65e-02 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 4.22e-02 | 1.83e-01 | 1.27e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 2.35e-01 | -1.83e-01 | 4.16e-01 |
APOPTOSIS | 163 | 5.61e-05 | 1.83e-01 | 6.65e-04 |
LAGGING STRAND SYNTHESIS | 20 | 1.57e-01 | 1.83e-01 | 3.23e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 11 | 2.96e-01 | 1.82e-01 | 4.73e-01 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.49e-01 | -1.82e-01 | 3.12e-01 |
RESOLUTION OF D LOOP STRUCTURES | 30 | 8.49e-02 | -1.82e-01 | 2.11e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 13 | 2.57e-01 | 1.82e-01 | 4.34e-01 |
RHOBTB GTPASE CYCLE | 35 | 6.31e-02 | 1.82e-01 | 1.72e-01 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 8.53e-02 | 1.82e-01 | 2.11e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 20 | 1.60e-01 | 1.81e-01 | 3.27e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 2.59e-01 | 1.81e-01 | 4.36e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 1.61e-01 | -1.81e-01 | 3.28e-01 |
INTEGRIN SIGNALING | 24 | 1.25e-01 | 1.81e-01 | 2.78e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 2.75e-02 | -1.80e-01 | 9.45e-02 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 1.74e-01 | 1.80e-01 | 3.49e-01 |
CGMP EFFECTS | 15 | 2.27e-01 | -1.80e-01 | 4.06e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 1.99e-01 | 1.80e-01 | 3.78e-01 |
RAP1 SIGNALLING | 15 | 2.28e-01 | 1.80e-01 | 4.06e-01 |
INTERLEUKIN 7 SIGNALING | 20 | 1.65e-01 | -1.79e-01 | 3.33e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 17 | 2.01e-01 | 1.79e-01 | 3.79e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 1.15e-01 | 1.79e-01 | 2.61e-01 |
HIV INFECTION | 221 | 4.93e-06 | 1.79e-01 | 9.19e-05 |
SEPARATION OF SISTER CHROMATIDS | 164 | 8.64e-05 | 1.78e-01 | 9.16e-04 |
MUCOPOLYSACCHARIDOSES | 11 | 3.07e-01 | 1.78e-01 | 4.83e-01 |
KERATAN SULFATE DEGRADATION | 11 | 3.09e-01 | 1.77e-01 | 4.85e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 62 | 1.59e-02 | 1.77e-01 | 6.48e-02 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 1.94e-01 | -1.77e-01 | 3.70e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 4.74e-02 | 1.77e-01 | 1.39e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 93 | 3.31e-03 | 1.76e-01 | 1.82e-02 |
MITOTIC METAPHASE AND ANAPHASE | 204 | 1.45e-05 | 1.76e-01 | 2.23e-04 |
INTERLEUKIN 10 SIGNALING | 17 | 2.09e-01 | 1.76e-01 | 3.84e-01 |
SYNTHESIS OF PC | 25 | 1.28e-01 | 1.76e-01 | 2.81e-01 |
GP1B IX V ACTIVATION SIGNALLING | 11 | 3.13e-01 | -1.76e-01 | 4.88e-01 |
HEME BIOSYNTHESIS | 13 | 2.73e-01 | 1.76e-01 | 4.51e-01 |
G ALPHA Z SIGNALLING EVENTS | 45 | 4.16e-02 | 1.76e-01 | 1.26e-01 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 3.36e-01 | -1.76e-01 | 5.13e-01 |
SIGNALING BY INTERLEUKINS | 346 | 2.19e-08 | 1.75e-01 | 9.13e-07 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 1.38e-01 | 1.75e-01 | 2.96e-01 |
UB SPECIFIC PROCESSING PROTEASES | 166 | 1.14e-04 | 1.74e-01 | 1.15e-03 |
REGULATION OF FZD BY UBIQUITINATION | 19 | 1.91e-01 | 1.73e-01 | 3.68e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 1.92e-01 | 1.73e-01 | 3.68e-01 |
TELOMERE EXTENSION BY TELOMERASE | 23 | 1.51e-01 | -1.73e-01 | 3.16e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 3.01e-01 | 1.72e-01 | 4.79e-01 |
COLLAGEN FORMATION | 77 | 9.34e-03 | -1.71e-01 | 4.19e-02 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 1.30e-01 | 1.71e-01 | 2.85e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 3.25e-01 | 1.71e-01 | 5.03e-01 |
RHOQ GTPASE CYCLE | 58 | 2.49e-02 | 1.70e-01 | 8.76e-02 |
G ALPHA I SIGNALLING EVENTS | 193 | 4.68e-05 | 1.70e-01 | 5.75e-04 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 2.71e-01 | -1.70e-01 | 4.49e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 138 | 5.96e-04 | 1.69e-01 | 4.86e-03 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 4.18e-03 | -1.69e-01 | 2.19e-02 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 1.29e-01 | 1.69e-01 | 2.82e-01 |
HSF1 ACTIVATION | 26 | 1.39e-01 | 1.68e-01 | 2.96e-01 |
HDMS DEMETHYLATE HISTONES | 27 | 1.31e-01 | -1.68e-01 | 2.86e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 2.61e-02 | 1.67e-01 | 9.04e-02 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 49 | 4.43e-02 | -1.66e-01 | 1.33e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 11 | 3.41e-01 | 1.66e-01 | 5.17e-01 |
SIGNALING BY FGFR1 IN DISEASE | 32 | 1.06e-01 | 1.65e-01 | 2.46e-01 |
RND3 GTPASE CYCLE | 38 | 7.87e-02 | -1.65e-01 | 2.00e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 9.83e-02 | 1.64e-01 | 2.35e-01 |
SIGNALING BY VEGF | 102 | 4.39e-03 | 1.63e-01 | 2.28e-02 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 6.40e-02 | 1.63e-01 | 1.74e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 1.74e-02 | -1.63e-01 | 6.90e-02 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 1.29e-01 | 1.63e-01 | 2.82e-01 |
G2 M CHECKPOINTS | 133 | 1.19e-03 | 1.63e-01 | 8.16e-03 |
DSCAM INTERACTIONS | 11 | 3.50e-01 | -1.63e-01 | 5.25e-01 |
POLYMERASE SWITCHING | 14 | 2.93e-01 | 1.62e-01 | 4.71e-01 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 59 | 3.10e-02 | -1.62e-01 | 1.02e-01 |
AMYLOID FIBER FORMATION | 56 | 3.56e-02 | 1.62e-01 | 1.11e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 1.98e-04 | 1.62e-01 | 1.83e-03 |
TOLL LIKE RECEPTOR CASCADES | 137 | 1.05e-03 | 1.62e-01 | 7.51e-03 |
SIGNALING BY FGFR IN DISEASE | 55 | 3.80e-02 | 1.62e-01 | 1.17e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 3.13e-01 | -1.62e-01 | 4.88e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 2.80e-01 | 1.61e-01 | 4.59e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 21 | 2.01e-01 | 1.61e-01 | 3.79e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 1.47e-01 | 1.61e-01 | 3.10e-01 |
METABOLISM OF CARBOHYDRATES | 258 | 8.87e-06 | 1.61e-01 | 1.48e-04 |
REPRESSION OF WNT TARGET GENES | 14 | 2.98e-01 | 1.61e-01 | 4.74e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 2.39e-01 | 1.60e-01 | 4.17e-01 |
AUTOPHAGY | 138 | 1.17e-03 | 1.60e-01 | 8.10e-03 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 5.27e-02 | 1.60e-01 | 1.49e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 96 | 6.80e-03 | 1.60e-01 | 3.21e-02 |
LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 1.25e-01 | 1.59e-01 | 2.78e-01 |
SELECTIVE AUTOPHAGY | 72 | 1.99e-02 | 1.59e-01 | 7.53e-02 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 21 | 2.08e-01 | 1.59e-01 | 3.84e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 2.88e-01 | 1.58e-01 | 4.67e-01 |
METAL ION SLC TRANSPORTERS | 24 | 1.79e-01 | 1.58e-01 | 3.55e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 597 | 5.41e-11 | 1.58e-01 | 3.16e-09 |
PEPTIDE HORMONE METABOLISM | 58 | 3.80e-02 | 1.58e-01 | 1.17e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 2.11e-01 | 1.58e-01 | 3.87e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 1.42e-01 | -1.58e-01 | 3.03e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 2.75e-01 | -1.57e-01 | 4.53e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 2.61e-01 | 1.57e-01 | 4.39e-01 |
CHROMATIN MODIFYING ENZYMES | 217 | 6.68e-05 | -1.57e-01 | 7.35e-04 |
HDACS DEACETYLATE HISTONES | 45 | 6.82e-02 | -1.57e-01 | 1.83e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 2.13e-01 | 1.57e-01 | 3.89e-01 |
BASIGIN INTERACTIONS | 22 | 2.04e-01 | 1.57e-01 | 3.80e-01 |
NUCLEOBASE CATABOLISM | 31 | 1.32e-01 | 1.56e-01 | 2.88e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 3.30e-01 | 1.56e-01 | 5.08e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 1.29e-02 | -1.56e-01 | 5.42e-02 |
P75NTR REGULATES AXONOGENESIS | 10 | 3.95e-01 | 1.55e-01 | 5.63e-01 |
SIGNALING BY ERBB4 | 57 | 4.27e-02 | 1.55e-01 | 1.29e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 1.79e-02 | -1.55e-01 | 7.04e-02 |
MTORC1 MEDIATED SIGNALLING | 24 | 1.89e-01 | 1.55e-01 | 3.66e-01 |
INTERLEUKIN 37 SIGNALING | 19 | 2.45e-01 | 1.54e-01 | 4.22e-01 |
RHOG GTPASE CYCLE | 73 | 2.34e-02 | 1.53e-01 | 8.50e-02 |
FERTILIZATION | 12 | 3.58e-01 | -1.53e-01 | 5.29e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 138 | 1.91e-03 | 1.53e-01 | 1.22e-02 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 12 | 3.58e-01 | 1.53e-01 | 5.29e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 178 | 4.33e-04 | 1.53e-01 | 3.64e-03 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 2.48e-02 | 1.53e-01 | 8.76e-02 |
NRAGE SIGNALS DEATH THROUGH JNK | 56 | 4.78e-02 | -1.53e-01 | 1.39e-01 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 13 | 3.40e-01 | -1.53e-01 | 5.17e-01 |
NEDDYLATION | 216 | 1.12e-04 | 1.53e-01 | 1.13e-03 |
ACYL CHAIN REMODELLING OF PE | 16 | 2.91e-01 | 1.52e-01 | 4.71e-01 |
PROTEIN FOLDING | 88 | 1.38e-02 | 1.52e-01 | 5.72e-02 |
SIGNALING BY WNT | 266 | 2.10e-05 | 1.52e-01 | 2.96e-04 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 1.98e-01 | -1.52e-01 | 3.76e-01 |
PLATELET AGGREGATION PLUG FORMATION | 33 | 1.34e-01 | 1.51e-01 | 2.90e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 2.82e-01 | -1.51e-01 | 4.60e-01 |
DISEASES OF DNA REPAIR | 11 | 3.87e-01 | -1.51e-01 | 5.57e-01 |
STIMULI SENSING CHANNELS | 74 | 2.53e-02 | -1.50e-01 | 8.87e-02 |
SYNTHESIS OF PE | 12 | 3.67e-01 | -1.50e-01 | 5.39e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 3.30e-01 | -1.50e-01 | 5.08e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 3.69e-01 | -1.50e-01 | 5.40e-01 |
PECAM1 INTERACTIONS | 12 | 3.70e-01 | 1.49e-01 | 5.40e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 3.70e-01 | 1.49e-01 | 5.40e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 7.40e-02 | 1.49e-01 | 1.94e-01 |
REGULATION OF IFNG SIGNALING | 13 | 3.52e-01 | 1.49e-01 | 5.28e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 2.51e-01 | 1.48e-01 | 4.28e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 3.05e-01 | 1.48e-01 | 4.82e-01 |
TP53 REGULATES METABOLIC GENES | 84 | 1.89e-02 | 1.48e-01 | 7.31e-02 |
METABOLISM OF NUCLEOTIDES | 91 | 1.47e-02 | 1.48e-01 | 6.03e-02 |
COLLAGEN DEGRADATION | 49 | 7.43e-02 | -1.47e-01 | 1.94e-01 |
SIGNALING BY ERBB2 | 48 | 8.01e-02 | 1.46e-01 | 2.02e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 43 | 9.86e-02 | 1.46e-01 | 2.35e-01 |
DISEASES OF IMMUNE SYSTEM | 23 | 2.28e-01 | 1.45e-01 | 4.06e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 3.48e-01 | 1.45e-01 | 5.24e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 3.52e-01 | 1.44e-01 | 5.27e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 29 | 1.81e-01 | -1.44e-01 | 3.58e-01 |
SIGNALING BY PTK6 | 50 | 8.01e-02 | 1.43e-01 | 2.02e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 3.73e-01 | -1.43e-01 | 5.43e-01 |
SIALIC ACID METABOLISM | 32 | 1.63e-01 | 1.42e-01 | 3.30e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 2.96e-01 | -1.42e-01 | 4.73e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 2.96e-01 | -1.42e-01 | 4.73e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 2.37e-02 | 1.42e-01 | 8.55e-02 |
OLFACTORY SIGNALING PATHWAY | 23 | 2.40e-01 | 1.42e-01 | 4.18e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 2.51e-01 | 1.42e-01 | 4.28e-01 |
LONG TERM POTENTIATION | 23 | 2.42e-01 | -1.41e-01 | 4.18e-01 |
SIGNALING BY FGFR2 | 64 | 5.11e-02 | 1.41e-01 | 1.45e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 28 | 1.97e-01 | 1.41e-01 | 3.76e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 4.00e-01 | 1.40e-01 | 5.68e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 1.91e-01 | -1.40e-01 | 3.68e-01 |
LEISHMANIA INFECTION | 193 | 7.88e-04 | 1.40e-01 | 5.82e-03 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 1.52e-01 | -1.40e-01 | 3.16e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 1.92e-01 | 1.40e-01 | 3.68e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 1.36e-01 | -1.40e-01 | 2.94e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 3.35e-01 | 1.39e-01 | 5.12e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 3.67e-01 | 1.39e-01 | 5.39e-01 |
GPCR LIGAND BINDING | 259 | 1.18e-04 | 1.39e-01 | 1.16e-03 |
RA BIOSYNTHESIS PATHWAY | 12 | 4.04e-01 | 1.39e-01 | 5.72e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 2.39e-01 | 1.39e-01 | 4.17e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 24 | 2.39e-01 | 1.39e-01 | 4.17e-01 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 3.22e-01 | -1.39e-01 | 4.99e-01 |
SURFACTANT METABOLISM | 16 | 3.37e-01 | 1.39e-01 | 5.14e-01 |
NGF STIMULATED TRANSCRIPTION | 37 | 1.46e-01 | 1.38e-01 | 3.08e-01 |
INTERLEUKIN 35 SIGNALLING | 10 | 4.50e-01 | 1.38e-01 | 6.12e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 17 | 3.25e-01 | -1.38e-01 | 5.03e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 2.75e-01 | 1.38e-01 | 4.53e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 4.53e-01 | -1.37e-01 | 6.15e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 1.87e-01 | -1.37e-01 | 3.65e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 8.55e-02 | 1.37e-01 | 2.11e-01 |
CD28 CO STIMULATION | 29 | 2.04e-01 | 1.36e-01 | 3.80e-01 |
HEMOSTASIS | 471 | 4.75e-07 | 1.36e-01 | 1.39e-05 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 3.80e-01 | 1.36e-01 | 5.50e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 6.81e-02 | -1.35e-01 | 1.83e-01 |
HS GAG BIOSYNTHESIS | 29 | 2.08e-01 | 1.35e-01 | 3.84e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 2.53e-01 | 1.35e-01 | 4.29e-01 |
MET ACTIVATES RAS SIGNALING | 10 | 4.61e-01 | 1.35e-01 | 6.20e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 2.44e-01 | 1.35e-01 | 4.21e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 4.20e-01 | 1.35e-01 | 5.84e-01 |
CELL CYCLE CHECKPOINTS | 241 | 3.33e-04 | 1.34e-01 | 2.94e-03 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 2.18e-01 | -1.34e-01 | 3.95e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 283 | 1.09e-04 | 1.34e-01 | 1.11e-03 |
SIGNALING BY EGFR | 47 | 1.12e-01 | 1.34e-01 | 2.56e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 1.54e-01 | 1.34e-01 | 3.18e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 7.33e-02 | -1.34e-01 | 1.93e-01 |
DNA STRAND ELONGATION | 32 | 1.90e-01 | 1.34e-01 | 3.68e-01 |
TIGHT JUNCTION INTERACTIONS | 18 | 3.26e-01 | 1.34e-01 | 5.03e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 4.43e-01 | 1.34e-01 | 6.06e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 34 | 1.78e-01 | 1.33e-01 | 3.54e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 3.66e-02 | 1.33e-01 | 1.14e-01 |
ADAPTIVE IMMUNE SYSTEM | 594 | 3.69e-08 | 1.33e-01 | 1.49e-06 |
SIGNALING BY FGFR | 74 | 4.96e-02 | 1.32e-01 | 1.43e-01 |
VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 3.93e-01 | 1.32e-01 | 5.62e-01 |
RHO GTPASES ACTIVATE IQGAPS | 24 | 2.65e-01 | 1.32e-01 | 4.42e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 1.91e-01 | 1.31e-01 | 3.68e-01 |
RND2 GTPASE CYCLE | 38 | 1.62e-01 | -1.31e-01 | 3.28e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 133 | 9.20e-03 | 1.31e-01 | 4.14e-02 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 43 | 1.38e-01 | 1.31e-01 | 2.96e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 105 | 2.10e-02 | -1.30e-01 | 7.79e-02 |
HEDGEHOG OFF STATE | 106 | 2.05e-02 | 1.30e-01 | 7.67e-02 |
CARGO CONCENTRATION IN THE ER | 31 | 2.11e-01 | 1.30e-01 | 3.87e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 93 | 3.12e-02 | 1.29e-01 | 1.02e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 1.58e-01 | -1.29e-01 | 3.24e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 4.82e-01 | -1.29e-01 | 6.37e-01 |
AMINE LIGAND BINDING RECEPTORS | 31 | 2.16e-01 | 1.28e-01 | 3.92e-01 |
DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 4.41e-01 | 1.28e-01 | 6.05e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 3.91e-01 | 1.28e-01 | 5.60e-01 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 4.85e-01 | -1.27e-01 | 6.40e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 2.28e-01 | 1.27e-01 | 4.06e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 3.02e-01 | 1.27e-01 | 4.80e-01 |
REGULATION OF IFNA SIGNALING | 12 | 4.46e-01 | -1.27e-01 | 6.09e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 4.88e-01 | 1.27e-01 | 6.43e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 69 | 6.93e-02 | 1.27e-01 | 1.85e-01 |
ELASTIC FIBRE FORMATION | 36 | 1.89e-01 | 1.27e-01 | 3.66e-01 |
MRNA SPLICING | 188 | 2.82e-03 | 1.26e-01 | 1.64e-02 |
DEUBIQUITINATION | 240 | 7.56e-04 | 1.26e-01 | 5.77e-03 |
SIGNALING BY LEPTIN | 10 | 4.89e-01 | -1.26e-01 | 6.43e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 114 | 1.99e-02 | 1.26e-01 | 7.53e-02 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 4.69e-01 | -1.26e-01 | 6.26e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 1.63e-01 | 1.26e-01 | 3.30e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 341 | 6.63e-05 | 1.26e-01 | 7.35e-04 |
PROCESSING OF SMDT1 | 16 | 3.84e-01 | 1.26e-01 | 5.55e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 90 | 3.96e-02 | 1.26e-01 | 1.22e-01 |
RHO GTPASE EFFECTORS | 247 | 6.98e-04 | 1.25e-01 | 5.47e-03 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 1.46e-01 | 1.25e-01 | 3.08e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 4.61e-02 | -1.25e-01 | 1.37e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 3.45e-01 | -1.25e-01 | 5.23e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 31 | 2.29e-01 | -1.25e-01 | 4.07e-01 |
RHOV GTPASE CYCLE | 32 | 2.23e-01 | -1.25e-01 | 4.00e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 1.25e-01 | 1.24e-01 | 2.78e-01 |
O LINKED GLYCOSYLATION | 85 | 4.80e-02 | -1.24e-01 | 1.39e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 31 | 2.33e-01 | 1.24e-01 | 4.13e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 4.41e-01 | 1.23e-01 | 6.05e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 3.54e-01 | -1.23e-01 | 5.29e-01 |
SIGNALING BY MET | 75 | 6.63e-02 | 1.23e-01 | 1.79e-01 |
G ALPHA Q SIGNALLING EVENTS | 154 | 8.95e-03 | 1.22e-01 | 4.08e-02 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.63e-01 | 1.22e-01 | 4.41e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 5.04e-01 | -1.22e-01 | 6.57e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 101 | 3.47e-02 | 1.22e-01 | 1.11e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 3.13e-01 | 1.22e-01 | 4.88e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 3.47e-01 | 1.22e-01 | 5.23e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 3.35e-01 | 1.22e-01 | 5.12e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 2.42e-01 | -1.22e-01 | 4.18e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 1.07e-01 | 1.22e-01 | 2.47e-01 |
CILIUM ASSEMBLY | 189 | 4.14e-03 | -1.21e-01 | 2.17e-02 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 37 | 2.03e-01 | 1.21e-01 | 3.80e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 2.04e-01 | -1.21e-01 | 3.81e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 2.11e-01 | 1.20e-01 | 3.87e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 3.57e-01 | -1.19e-01 | 5.29e-01 |
METABOLISM OF LIPIDS | 608 | 6.27e-07 | 1.19e-01 | 1.78e-05 |
RORA ACTIVATES GENE EXPRESSION | 18 | 3.84e-01 | -1.18e-01 | 5.55e-01 |
INTERLEUKIN 27 SIGNALING | 10 | 5.18e-01 | 1.18e-01 | 6.69e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 219 | 2.76e-03 | 1.18e-01 | 1.61e-02 |
PLATELET HOMEOSTASIS | 76 | 7.80e-02 | 1.17e-01 | 1.99e-01 |
RHOJ GTPASE CYCLE | 54 | 1.38e-01 | 1.17e-01 | 2.96e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 4.35e-01 | -1.16e-01 | 5.99e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 34 | 2.41e-01 | -1.16e-01 | 4.18e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 3.35e-01 | -1.16e-01 | 5.12e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 537 | 4.50e-06 | 1.16e-01 | 8.91e-05 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 6.18e-02 | 1.16e-01 | 1.68e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 2.01e-01 | -1.15e-01 | 3.79e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 4.57e-01 | 1.15e-01 | 6.16e-01 |
COPII MEDIATED VESICLE TRANSPORT | 66 | 1.07e-01 | 1.15e-01 | 2.48e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 3.75e-01 | 1.15e-01 | 5.45e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 1.21e-01 | 1.14e-01 | 2.71e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 2.07e-01 | -1.14e-01 | 3.82e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 4.95e-01 | 1.14e-01 | 6.49e-01 |
SIGNALING BY NODAL | 15 | 4.45e-01 | 1.14e-01 | 6.08e-01 |
CELLULAR HEXOSE TRANSPORT | 11 | 5.14e-01 | -1.14e-01 | 6.65e-01 |
DUAL INCISION IN GG NER | 40 | 2.15e-01 | 1.13e-01 | 3.91e-01 |
TBC RABGAPS | 43 | 2.00e-01 | 1.13e-01 | 3.78e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 2.94e-01 | 1.13e-01 | 4.71e-01 |
METABOLISM OF RNA | 643 | 1.30e-06 | 1.12e-01 | 3.15e-05 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 2.58e-01 | -1.12e-01 | 4.35e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 5.02e-01 | 1.12e-01 | 6.54e-01 |
INTEGRATION OF ENERGY METABOLISM | 98 | 5.57e-02 | 1.12e-01 | 1.56e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 3.77e-01 | -1.11e-01 | 5.47e-01 |
EGFR DOWNREGULATION | 28 | 3.09e-01 | 1.11e-01 | 4.85e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 9.21e-02 | 1.11e-01 | 2.24e-01 |
MAPK FAMILY SIGNALING CASCADES | 287 | 1.23e-03 | 1.11e-01 | 8.37e-03 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 3.78e-01 | 1.11e-01 | 5.48e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 3.29e-01 | -1.11e-01 | 5.07e-01 |
SYNTHESIS OF PA | 29 | 3.03e-01 | 1.10e-01 | 4.81e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 100 | 5.71e-02 | 1.10e-01 | 1.58e-01 |
RND1 GTPASE CYCLE | 38 | 2.41e-01 | -1.10e-01 | 4.18e-01 |
EPH EPHRIN SIGNALING | 90 | 7.19e-02 | 1.10e-01 | 1.90e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 2.35e-01 | 1.10e-01 | 4.16e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 49 | 1.84e-01 | 1.10e-01 | 3.61e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 4.79e-01 | -1.09e-01 | 6.36e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 5.30e-01 | 1.09e-01 | 6.78e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 1.35e-01 | 1.09e-01 | 2.91e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 4.24e-01 | -1.09e-01 | 5.87e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 2.94e-01 | 1.09e-01 | 4.72e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 3.47e-01 | 1.09e-01 | 5.23e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 2.88e-01 | 1.09e-01 | 4.67e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 4.54e-01 | 1.08e-01 | 6.15e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 3.23e-01 | 1.08e-01 | 5.00e-01 |
ZINC TRANSPORTERS | 15 | 4.69e-01 | 1.08e-01 | 6.26e-01 |
FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 5.55e-01 | 1.08e-01 | 6.97e-01 |
TRNA PROCESSING | 105 | 5.64e-02 | -1.08e-01 | 1.57e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 3.61e-01 | 1.08e-01 | 5.32e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 114 | 4.69e-02 | 1.08e-01 | 1.38e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 38 | 2.53e-01 | 1.07e-01 | 4.29e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 4.89e-01 | 1.07e-01 | 6.43e-01 |
PLATELET CALCIUM HOMEOSTASIS | 25 | 3.57e-01 | -1.07e-01 | 5.29e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 7.63e-02 | 1.06e-01 | 1.97e-01 |
TRANSPORT OF SMALL MOLECULES | 566 | 1.76e-05 | 1.06e-01 | 2.60e-04 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 5.44e-01 | 1.06e-01 | 6.89e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 21 | 4.01e-01 | 1.06e-01 | 5.69e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 1.11e-01 | 1.06e-01 | 2.54e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 2.81e-01 | -1.05e-01 | 4.60e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 3.63e-01 | 1.05e-01 | 5.35e-01 |
FANCONI ANEMIA PATHWAY | 36 | 2.76e-01 | -1.05e-01 | 4.54e-01 |
CARNITINE METABOLISM | 14 | 4.97e-01 | 1.05e-01 | 6.50e-01 |
GLUCOSE METABOLISM | 80 | 1.05e-01 | 1.05e-01 | 2.46e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 43 | 2.37e-01 | -1.04e-01 | 4.16e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 10 | 5.68e-01 | 1.04e-01 | 7.08e-01 |
DUAL INCISION IN TC NER | 64 | 1.54e-01 | 1.03e-01 | 3.19e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 2.15e-01 | 1.02e-01 | 3.91e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 3.86e-01 | -1.02e-01 | 5.56e-01 |
RECYCLING PATHWAY OF L1 | 40 | 2.66e-01 | 1.02e-01 | 4.44e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 3.39e-01 | -1.01e-01 | 5.15e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 2.06e-01 | 1.01e-01 | 3.81e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 3.85e-01 | -1.00e-01 | 5.55e-01 |
NUCLEOTIDE EXCISION REPAIR | 109 | 7.05e-02 | 1.00e-01 | 1.88e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 28 | 3.58e-01 | -1.00e-01 | 5.29e-01 |
KERATINIZATION | 28 | 3.58e-01 | -1.00e-01 | 5.29e-01 |
ESR MEDIATED SIGNALING | 163 | 2.81e-02 | 9.98e-02 | 9.54e-02 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 59 | 1.86e-01 | -9.96e-02 | 3.64e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 1.02e-01 | 9.94e-02 | 2.39e-01 |
ERK MAPK TARGETS | 22 | 4.24e-01 | 9.85e-02 | 5.87e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 2.56e-01 | 9.79e-02 | 4.34e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 5.58e-01 | 9.76e-02 | 6.99e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 5.94e-01 | 9.75e-02 | 7.26e-01 |
MITOTIC SPINDLE CHECKPOINT | 96 | 9.91e-02 | 9.75e-02 | 2.36e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 76 | 1.42e-01 | 9.74e-02 | 3.03e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 4.20e-01 | 9.72e-02 | 5.84e-01 |
REGULATION OF INSULIN SECRETION | 71 | 1.58e-01 | 9.69e-02 | 3.25e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 2.66e-01 | 9.69e-02 | 4.44e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.46e-01 | 9.68e-02 | 6.91e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 284 | 5.17e-03 | 9.66e-02 | 2.59e-02 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 84 | 1.26e-01 | -9.66e-02 | 2.78e-01 |
METABOLISM OF STEROIDS | 111 | 8.05e-02 | 9.61e-02 | 2.02e-01 |
RAC2 GTPASE CYCLE | 86 | 1.25e-01 | 9.56e-02 | 2.78e-01 |
INSULIN PROCESSING | 24 | 4.23e-01 | 9.45e-02 | 5.87e-01 |
SIGNALING BY HEDGEHOG | 141 | 5.31e-02 | 9.45e-02 | 1.50e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 50 | 2.52e-01 | 9.36e-02 | 4.29e-01 |
STRIATED MUSCLE CONTRACTION | 26 | 4.10e-01 | -9.33e-02 | 5.77e-01 |
RHO GTPASES ACTIVATE FORMINS | 118 | 8.05e-02 | 9.32e-02 | 2.02e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 1.26e-01 | 9.24e-02 | 2.78e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 48 | 2.69e-01 | 9.23e-02 | 4.46e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1206 | 9.32e-08 | 9.21e-02 | 3.26e-06 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 4.08e-01 | -9.21e-02 | 5.75e-01 |
G PROTEIN MEDIATED EVENTS | 52 | 2.52e-01 | 9.19e-02 | 4.29e-01 |
NERVOUS SYSTEM DEVELOPMENT | 546 | 2.53e-04 | 9.19e-02 | 2.29e-03 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 365 | 2.63e-03 | 9.19e-02 | 1.54e-02 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 66 | 1.98e-01 | -9.17e-02 | 3.76e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 3.10e-01 | 9.17e-02 | 4.85e-01 |
RAB REGULATION OF TRAFFICKING | 118 | 8.56e-02 | 9.17e-02 | 2.11e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 3.70e-01 | -9.17e-02 | 5.40e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 2.09e-01 | 9.15e-02 | 3.84e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 5.27e-01 | -9.14e-02 | 6.78e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 45 | 2.94e-01 | 9.05e-02 | 4.71e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 4.95e-01 | 9.04e-02 | 6.49e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 4.08e-01 | -9.03e-02 | 5.76e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 5.77e-01 | 8.95e-02 | 7.15e-01 |
GENE SILENCING BY RNA | 83 | 1.60e-01 | -8.93e-02 | 3.27e-01 |
NETRIN 1 SIGNALING | 49 | 2.81e-01 | -8.91e-02 | 4.60e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 1.87e-02 | 8.88e-02 | 7.28e-02 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 6.10e-01 | -8.88e-02 | 7.40e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 18 | 5.15e-01 | 8.87e-02 | 6.66e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 5.80e-01 | -8.87e-02 | 7.18e-01 |
APOPTOTIC EXECUTION PHASE | 46 | 3.00e-01 | 8.84e-02 | 4.78e-01 |
SIGNALING BY GPCR | 476 | 1.01e-03 | 8.83e-02 | 7.25e-03 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 169 | 4.80e-02 | 8.83e-02 | 1.39e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 5.41e-01 | 8.82e-02 | 6.89e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 5.29e-01 | -8.82e-02 | 6.78e-01 |
HS GAG DEGRADATION | 20 | 4.96e-01 | -8.79e-02 | 6.49e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 5.84e-01 | 8.78e-02 | 7.19e-01 |
MEMBRANE TRAFFICKING | 579 | 3.95e-04 | 8.65e-02 | 3.34e-03 |
HCMV EARLY EVENTS | 79 | 1.84e-01 | -8.65e-02 | 3.61e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 4.73e-01 | 8.65e-02 | 6.30e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 11 | 6.20e-01 | 8.65e-02 | 7.46e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 5.06e-01 | 8.59e-02 | 6.58e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 5.18e-01 | 8.56e-02 | 6.69e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 57 | 2.64e-01 | -8.55e-02 | 4.42e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 5.69e-01 | -8.48e-02 | 7.09e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 3.05e-01 | 8.47e-02 | 4.82e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 5.46e-01 | -8.46e-02 | 6.91e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 463 | 2.10e-03 | 8.37e-02 | 1.29e-02 |
OXIDATIVE STRESS INDUCED SENESCENCE | 78 | 2.02e-01 | -8.36e-02 | 3.79e-01 |
LYSINE CATABOLISM | 11 | 6.32e-01 | 8.33e-02 | 7.54e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 6.03e-01 | 8.33e-02 | 7.36e-01 |
PTEN REGULATION | 134 | 9.64e-02 | 8.33e-02 | 2.32e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 18 | 5.42e-01 | -8.31e-02 | 6.89e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 2.71e-01 | -8.29e-02 | 4.49e-01 |
SIGNALING BY NTRKS | 131 | 1.03e-01 | 8.25e-02 | 2.42e-01 |
HATS ACETYLATE HISTONES | 91 | 1.75e-01 | -8.23e-02 | 3.50e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 63 | 2.61e-01 | 8.20e-02 | 4.39e-01 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 5.84e-01 | -8.17e-02 | 7.19e-01 |
MYOGENESIS | 25 | 4.79e-01 | -8.17e-02 | 6.36e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 4.55e-01 | 8.17e-02 | 6.15e-01 |
HIV LIFE CYCLE | 143 | 9.23e-02 | 8.16e-02 | 2.24e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 43 | 3.55e-01 | -8.16e-02 | 5.29e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 63 | 2.64e-01 | -8.13e-02 | 4.42e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 13 | 6.12e-01 | 8.13e-02 | 7.41e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 5.40e-01 | 8.12e-02 | 6.89e-01 |
VESICLE MEDIATED TRANSPORT | 607 | 6.75e-04 | 8.12e-02 | 5.32e-03 |
CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 4.66e-01 | 8.12e-02 | 6.23e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 6.66e-01 | 7.89e-02 | 7.84e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 3.18e-01 | -7.86e-02 | 4.94e-01 |
TNF SIGNALING | 43 | 3.75e-01 | 7.82e-02 | 5.45e-01 |
ECM PROTEOGLYCANS | 64 | 2.81e-01 | -7.80e-02 | 4.60e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 148 | 1.03e-01 | 7.77e-02 | 2.41e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 107 | 1.66e-01 | -7.75e-02 | 3.35e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 3.55e-01 | 7.72e-02 | 5.29e-01 |
MTOR SIGNALLING | 40 | 3.99e-01 | 7.71e-02 | 5.67e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 281 | 2.84e-02 | 7.61e-02 | 9.60e-02 |
SIGNALLING TO ERKS | 34 | 4.46e-01 | 7.56e-02 | 6.08e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 3.93e-01 | 7.54e-02 | 5.61e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 5.80e-01 | 7.53e-02 | 7.18e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 33 | 4.56e-01 | 7.50e-02 | 6.16e-01 |
M PHASE | 336 | 1.91e-02 | 7.46e-02 | 7.32e-02 |
POLO LIKE KINASE MEDIATED EVENTS | 13 | 6.44e-01 | 7.40e-02 | 7.64e-01 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 5.42e-01 | 7.35e-02 | 6.89e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 5.81e-01 | 7.32e-02 | 7.18e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 4.68e-01 | -7.30e-02 | 6.26e-01 |
CELL CYCLE MITOTIC | 470 | 7.02e-03 | 7.28e-02 | 3.28e-02 |
GAB1 SIGNALOSOME | 14 | 6.38e-01 | 7.27e-02 | 7.58e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 6.26e-01 | 7.27e-02 | 7.51e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 5.47e-01 | -7.26e-02 | 6.91e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 5.00e-01 | 7.25e-02 | 6.52e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 6.27e-01 | 7.24e-02 | 7.51e-01 |
CA2 PATHWAY | 56 | 3.53e-01 | 7.18e-02 | 5.28e-01 |
INOSITOL PHOSPHATE METABOLISM | 47 | 3.95e-01 | 7.17e-02 | 5.63e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 35 | 4.64e-01 | 7.15e-02 | 6.22e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 4.26e-01 | -7.10e-02 | 5.89e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 3.34e-01 | -7.09e-02 | 5.12e-01 |
CELL JUNCTION ORGANIZATION | 75 | 2.93e-01 | 7.03e-02 | 4.71e-01 |
DNA REPAIR | 291 | 4.12e-02 | -6.97e-02 | 1.25e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 5.64e-01 | 6.94e-02 | 7.05e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 22 | 5.74e-01 | -6.93e-02 | 7.13e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 4.85e-01 | 6.92e-02 | 6.40e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 5.75e-01 | 6.91e-02 | 7.13e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 26 | 5.43e-01 | 6.89e-02 | 6.89e-01 |
ION TRANSPORT BY P TYPE ATPASES | 47 | 4.18e-01 | -6.83e-02 | 5.84e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 5.12e-01 | 6.81e-02 | 6.64e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 5.65e-01 | 6.79e-02 | 7.05e-01 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 3.07e-01 | 6.78e-02 | 4.83e-01 |
NEUREXINS AND NEUROLIGINS | 54 | 3.94e-01 | -6.71e-02 | 5.62e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 3.43e-01 | 6.70e-02 | 5.20e-01 |
ENDOGENOUS STEROLS | 21 | 5.95e-01 | 6.70e-02 | 7.27e-01 |
CELLULAR SENESCENCE | 141 | 1.71e-01 | -6.69e-02 | 3.43e-01 |
CDC42 GTPASE CYCLE | 153 | 1.54e-01 | -6.69e-02 | 3.18e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 6.07e-01 | -6.64e-02 | 7.38e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 7.17e-01 | -6.62e-02 | 8.27e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 107 | 2.38e-01 | 6.61e-02 | 4.17e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 6.80e-01 | -6.61e-02 | 7.97e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 6.50e-01 | 6.56e-02 | 7.70e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 6.32e-01 | -6.53e-02 | 7.54e-01 |
RAC3 GTPASE CYCLE | 88 | 2.93e-01 | 6.49e-02 | 4.71e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 3.90e-01 | -6.47e-02 | 5.59e-01 |
DEVELOPMENTAL BIOLOGY | 809 | 1.87e-03 | 6.47e-02 | 1.20e-02 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 5.92e-01 | -6.46e-02 | 7.25e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 4.10e-01 | -6.43e-02 | 5.77e-01 |
SIGNALLING TO RAS | 20 | 6.20e-01 | -6.40e-02 | 7.46e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 6.22e-01 | -6.37e-02 | 7.47e-01 |
SIGNALING BY NOTCH2 | 33 | 5.27e-01 | -6.36e-02 | 6.78e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 47 | 4.51e-01 | 6.35e-02 | 6.13e-01 |
REGULATION OF KIT SIGNALING | 16 | 6.61e-01 | -6.33e-02 | 7.80e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 47 | 4.56e-01 | -6.28e-02 | 6.16e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 46 | 4.62e-01 | -6.27e-02 | 6.20e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 5.48e-01 | 6.24e-02 | 6.91e-01 |
METABOLISM OF STEROID HORMONES | 20 | 6.29e-01 | 6.24e-02 | 7.52e-01 |
SEMAPHORIN INTERACTIONS | 64 | 3.90e-01 | -6.22e-02 | 5.59e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 281 | 7.43e-02 | -6.20e-02 | 1.94e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 4.13e-01 | -6.17e-02 | 5.78e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 4.27e-01 | -6.14e-02 | 5.89e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 100 | 2.89e-01 | 6.14e-02 | 4.68e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 103 | 2.83e-01 | 6.13e-02 | 4.60e-01 |
CELL CELL COMMUNICATION | 107 | 2.75e-01 | 6.12e-02 | 4.53e-01 |
SIGNALING BY PDGF | 55 | 4.34e-01 | -6.10e-02 | 5.97e-01 |
RET SIGNALING | 37 | 5.22e-01 | 6.09e-02 | 6.72e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 5.92e-01 | -6.08e-02 | 7.25e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 5.29e-01 | 6.07e-02 | 6.78e-01 |
CA DEPENDENT EVENTS | 36 | 5.30e-01 | 6.05e-02 | 6.78e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 6.75e-01 | 6.05e-02 | 7.93e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 3.19e-01 | 6.01e-02 | 4.96e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 5.56e-01 | -6.01e-02 | 6.98e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 95 | 3.13e-01 | 5.99e-02 | 4.88e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 4.95e-01 | -5.88e-02 | 6.49e-01 |
NICOTINAMIDE SALVAGING | 15 | 6.95e-01 | -5.86e-02 | 8.10e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 141 | 2.31e-01 | 5.84e-02 | 4.11e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 6.14e-01 | 5.84e-02 | 7.42e-01 |
ION CHANNEL TRANSPORT | 138 | 2.39e-01 | -5.81e-02 | 4.17e-01 |
RHOF GTPASE CYCLE | 40 | 5.29e-01 | 5.76e-02 | 6.78e-01 |
CIRCADIAN CLOCK | 68 | 4.16e-01 | 5.70e-02 | 5.82e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 63 | 4.34e-01 | 5.70e-02 | 5.97e-01 |
FGFR2 ALTERNATIVE SPLICING | 26 | 6.15e-01 | -5.70e-02 | 7.43e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 5.51e-01 | -5.67e-02 | 6.94e-01 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 4.01e-01 | -5.64e-02 | 5.69e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 3.56e-01 | 5.63e-02 | 5.29e-01 |
SIGNALING BY NOTCH | 188 | 1.86e-01 | 5.60e-02 | 3.64e-01 |
THE PHOTOTRANSDUCTION CASCADE | 20 | 6.65e-01 | 5.60e-02 | 7.84e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 628 | 1.72e-02 | 5.60e-02 | 6.83e-02 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 183 | 1.92e-01 | 5.59e-02 | 3.68e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 136 | 2.61e-01 | -5.59e-02 | 4.39e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 7.49e-01 | -5.57e-02 | 8.53e-01 |
REPRODUCTION | 75 | 4.06e-01 | -5.55e-02 | 5.74e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 54 | 4.81e-01 | 5.55e-02 | 6.37e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 24 | 6.43e-01 | -5.46e-02 | 7.64e-01 |
MITOTIC PROPHASE | 92 | 3.69e-01 | 5.43e-02 | 5.40e-01 |
DISEASES OF METABOLISM | 198 | 1.89e-01 | 5.42e-02 | 3.66e-01 |
RNA POLYMERASE I TRANSCRIPTION | 67 | 4.44e-01 | 5.41e-02 | 6.08e-01 |
SIGNALING BY NOTCH1 | 75 | 4.19e-01 | -5.40e-02 | 5.84e-01 |
G ALPHA S SIGNALLING EVENTS | 103 | 3.46e-01 | 5.37e-02 | 5.23e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 3.47e-01 | -5.36e-02 | 5.23e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 6.82e-01 | 5.30e-02 | 7.98e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 6.28e-01 | -5.30e-02 | 7.51e-01 |
NOD1 2 SIGNALING PATHWAY | 35 | 5.88e-01 | 5.29e-02 | 7.22e-01 |
INTERFERON ALPHA BETA SIGNALING | 52 | 5.18e-01 | 5.18e-02 | 6.69e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 61 | 4.85e-01 | 5.17e-02 | 6.40e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 7.78e-01 | 5.14e-02 | 8.70e-01 |
UNWINDING OF DNA | 12 | 7.58e-01 | 5.14e-02 | 8.59e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 7.79e-01 | 5.12e-02 | 8.70e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 7.32e-01 | -5.10e-02 | 8.40e-01 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 7.71e-01 | -5.06e-02 | 8.67e-01 |
PI3K AKT SIGNALING IN CANCER | 88 | 4.12e-01 | 5.06e-02 | 5.78e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 6.98e-01 | 5.01e-02 | 8.12e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 47 | 5.53e-01 | 5.00e-02 | 6.96e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 7.74e-01 | 5.00e-02 | 8.68e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 235 | 1.88e-01 | 5.00e-02 | 3.65e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 7.56e-01 | 4.98e-02 | 8.58e-01 |
MITOTIC G2 G2 M PHASES | 184 | 2.47e-01 | 4.96e-02 | 4.23e-01 |
CHROMOSOME MAINTENANCE | 103 | 3.86e-01 | 4.94e-02 | 5.56e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 5.89e-01 | 4.87e-02 | 7.23e-01 |
TRNA AMINOACYLATION | 42 | 5.85e-01 | 4.87e-02 | 7.21e-01 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 7.71e-01 | 4.86e-02 | 8.67e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 6.20e-01 | -4.85e-02 | 7.46e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 6.11e-01 | -4.84e-02 | 7.40e-01 |
SIGNALING BY NOTCH3 | 48 | 5.68e-01 | -4.77e-02 | 7.08e-01 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 7.85e-01 | 4.74e-02 | 8.73e-01 |
CELL CYCLE | 588 | 5.06e-02 | 4.74e-02 | 1.44e-01 |
SENSORY PERCEPTION | 140 | 3.34e-01 | 4.73e-02 | 5.12e-01 |
NICOTINATE METABOLISM | 24 | 6.93e-01 | -4.66e-02 | 8.09e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 6.25e-01 | -4.64e-02 | 7.50e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 27 | 6.77e-01 | -4.64e-02 | 7.94e-01 |
HOMOLOGY DIRECTED REPAIR | 107 | 4.17e-01 | -4.55e-02 | 5.82e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 4.74e-01 | -4.55e-02 | 6.31e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 4.65e-01 | -4.54e-02 | 6.23e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 6.52e-01 | 4.54e-02 | 7.71e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 5.06e-01 | -4.47e-02 | 6.58e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 4.59e-01 | -4.40e-02 | 6.18e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 184 | 3.06e-01 | 4.38e-02 | 4.83e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 7.30e-01 | -4.36e-02 | 8.38e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 117 | 4.22e-01 | -4.30e-02 | 5.86e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 7.74e-01 | 4.29e-02 | 8.68e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 8.16e-01 | -4.25e-02 | 8.93e-01 |
CARDIAC CONDUCTION | 108 | 4.47e-01 | -4.24e-02 | 6.09e-01 |
PLASMA LIPOPROTEIN REMODELING | 15 | 7.77e-01 | -4.23e-02 | 8.70e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 5.57e-01 | 4.22e-02 | 6.98e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 6.37e-01 | -4.21e-02 | 7.58e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 8.10e-01 | 4.19e-02 | 8.91e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 7.68e-01 | 4.13e-02 | 8.65e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 30 | 6.97e-01 | 4.11e-02 | 8.12e-01 |
AGGREPHAGY | 35 | 6.75e-01 | 4.10e-02 | 7.93e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 19 | 7.59e-01 | -4.07e-02 | 8.59e-01 |
ATTENUATION PHASE | 24 | 7.31e-01 | 4.05e-02 | 8.39e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 5.53e-01 | -4.02e-02 | 6.96e-01 |
PYRIMIDINE CATABOLISM | 10 | 8.26e-01 | -4.02e-02 | 9.01e-01 |
SLC TRANSPORTER DISORDERS | 69 | 5.65e-01 | 4.01e-02 | 7.05e-01 |
SIGNALING BY ACTIVIN | 12 | 8.10e-01 | 4.01e-02 | 8.91e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 6.33e-01 | -3.98e-02 | 7.55e-01 |
LAMININ INTERACTIONS | 27 | 7.20e-01 | -3.98e-02 | 8.30e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 7.27e-01 | -3.96e-02 | 8.35e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 7.67e-01 | -3.93e-02 | 8.65e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 5.47e-01 | -3.92e-02 | 6.91e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 7.07e-01 | -3.90e-02 | 8.19e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 8.08e-01 | -3.90e-02 | 8.91e-01 |
DISEASES OF GLYCOSYLATION | 124 | 4.54e-01 | -3.89e-02 | 6.15e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 7.94e-01 | -3.89e-02 | 8.81e-01 |
PHOSPHOLIPID METABOLISM | 185 | 3.63e-01 | 3.88e-02 | 5.35e-01 |
NEPHRIN FAMILY INTERACTIONS | 22 | 7.55e-01 | 3.85e-02 | 8.58e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 7.85e-01 | 3.83e-02 | 8.73e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 35 | 6.98e-01 | 3.79e-02 | 8.12e-01 |
RHOC GTPASE CYCLE | 73 | 5.84e-01 | -3.71e-02 | 7.19e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 7.09e-01 | -3.70e-02 | 8.20e-01 |
GLYCOLYSIS | 66 | 6.05e-01 | 3.68e-02 | 7.37e-01 |
MEIOSIS | 63 | 6.14e-01 | -3.68e-02 | 7.42e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 7.25e-01 | 3.65e-02 | 8.34e-01 |
RHOB GTPASE CYCLE | 67 | 6.06e-01 | -3.64e-02 | 7.38e-01 |
MEIOTIC SYNAPSIS | 39 | 6.94e-01 | -3.64e-02 | 8.10e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 6.68e-01 | -3.62e-02 | 7.85e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 7.67e-01 | 3.58e-02 | 8.65e-01 |
MRNA CAPPING | 29 | 7.42e-01 | 3.54e-02 | 8.48e-01 |
RHO GTPASE CYCLE | 427 | 2.17e-01 | 3.49e-02 | 3.94e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 6.10e-01 | 3.46e-02 | 7.40e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 6.89e-01 | -3.45e-02 | 8.06e-01 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 175 | 4.33e-01 | 3.44e-02 | 5.97e-01 |
REGULATION OF TP53 ACTIVITY | 148 | 4.78e-01 | -3.39e-02 | 6.35e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 61 | 6.52e-01 | -3.34e-02 | 7.71e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 82 | 6.03e-01 | -3.33e-02 | 7.36e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 15 | 8.27e-01 | 3.26e-02 | 9.01e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 32 | 7.51e-01 | 3.24e-02 | 8.54e-01 |
INTERLEUKIN 17 SIGNALING | 66 | 6.55e-01 | 3.18e-02 | 7.73e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 239 | 4.12e-01 | -3.08e-02 | 5.78e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 52 | 7.03e-01 | 3.05e-02 | 8.17e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 51 | 7.09e-01 | 3.02e-02 | 8.20e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 8.33e-01 | 2.96e-02 | 9.04e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 118 | 5.87e-01 | 2.90e-02 | 7.22e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 8.58e-01 | -2.87e-02 | 9.23e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 176 | 5.13e-01 | 2.86e-02 | 6.65e-01 |
NUCLEOTIDE SALVAGE | 21 | 8.22e-01 | -2.84e-02 | 8.98e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 43 | 7.48e-01 | -2.83e-02 | 8.53e-01 |
RHOU GTPASE CYCLE | 33 | 7.82e-01 | -2.79e-02 | 8.72e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 8.35e-01 | 2.76e-02 | 9.04e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 31 | 7.91e-01 | 2.75e-02 | 8.79e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 62 | 7.13e-01 | 2.70e-02 | 8.23e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 8.35e-01 | -2.70e-02 | 9.04e-01 |
RAC1 GTPASE CYCLE | 177 | 5.38e-01 | 2.68e-02 | 6.87e-01 |
DNA METHYLATION | 20 | 8.36e-01 | -2.68e-02 | 9.04e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 8.41e-01 | 2.60e-02 | 9.07e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 8.00e-01 | -2.58e-02 | 8.85e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 8.63e-01 | -2.49e-02 | 9.28e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 8.69e-01 | -2.46e-02 | 9.28e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 8.35e-01 | 2.45e-02 | 9.04e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 7.11e-01 | 2.45e-02 | 8.21e-01 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 8.32e-01 | -2.41e-02 | 9.04e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 68 | 7.35e-01 | -2.37e-02 | 8.42e-01 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 8.69e-01 | 2.37e-02 | 9.28e-01 |
CELL CELL JUNCTION ORGANIZATION | 50 | 7.72e-01 | 2.37e-02 | 8.67e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 8.79e-01 | 2.35e-02 | 9.34e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 8.98e-01 | -2.35e-02 | 9.41e-01 |
VISUAL PHOTOTRANSDUCTION | 58 | 7.57e-01 | 2.35e-02 | 8.58e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 8.14e-01 | -2.33e-02 | 8.93e-01 |
ACYL CHAIN REMODELLING OF PS | 14 | 8.80e-01 | -2.32e-02 | 9.34e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 8.81e-01 | 2.31e-02 | 9.34e-01 |
POTASSIUM CHANNELS | 90 | 7.06e-01 | -2.30e-02 | 8.19e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 8.40e-01 | 2.29e-02 | 9.07e-01 |
EXTENSION OF TELOMERES | 50 | 7.83e-01 | -2.25e-02 | 8.72e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 8.94e-01 | 2.23e-02 | 9.39e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 34 | 8.22e-01 | 2.23e-02 | 8.98e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 8.03e-01 | 2.20e-02 | 8.87e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 40 | 8.11e-01 | 2.19e-02 | 8.91e-01 |
BASE EXCISION REPAIR | 56 | 7.77e-01 | -2.18e-02 | 8.70e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 20 | 8.69e-01 | -2.13e-02 | 9.28e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 8.95e-01 | 2.12e-02 | 9.39e-01 |
MITOTIC PROMETAPHASE | 175 | 6.36e-01 | -2.08e-02 | 7.58e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 7.98e-01 | -2.06e-02 | 8.83e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 9.12e-01 | 2.03e-02 | 9.49e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 37 | 8.32e-01 | -2.02e-02 | 9.04e-01 |
SENSORY PROCESSING OF SOUND | 61 | 7.85e-01 | 2.02e-02 | 8.73e-01 |
RHOD GTPASE CYCLE | 50 | 8.09e-01 | 1.98e-02 | 8.91e-01 |
MEIOTIC RECOMBINATION | 38 | 8.33e-01 | 1.97e-02 | 9.04e-01 |
TELOMERE MAINTENANCE | 79 | 7.62e-01 | 1.97e-02 | 8.61e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 8.71e-01 | -1.95e-02 | 9.29e-01 |
HCMV INFECTION | 102 | 7.36e-01 | -1.94e-02 | 8.42e-01 |
P38MAPK EVENTS | 13 | 9.08e-01 | -1.86e-02 | 9.47e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 55 | 8.12e-01 | 1.86e-02 | 8.91e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 8.68e-01 | 1.79e-02 | 9.28e-01 |
INTERLEUKIN 15 SIGNALING | 12 | 9.17e-01 | -1.74e-02 | 9.52e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 75 | 7.97e-01 | 1.72e-02 | 8.83e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 8.80e-01 | 1.71e-02 | 9.34e-01 |
RMTS METHYLATE HISTONE ARGININES | 42 | 8.49e-01 | -1.70e-02 | 9.14e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 9.14e-01 | 1.62e-02 | 9.50e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 8.87e-01 | -1.61e-02 | 9.37e-01 |
G0 AND EARLY G1 | 24 | 8.92e-01 | 1.60e-02 | 9.39e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 49 | 8.47e-01 | 1.60e-02 | 9.13e-01 |
RHOA GTPASE CYCLE | 143 | 7.43e-01 | 1.59e-02 | 8.49e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 8.70e-01 | -1.58e-02 | 9.28e-01 |
SNRNP ASSEMBLY | 51 | 8.47e-01 | -1.56e-02 | 9.13e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 9.02e-01 | 1.55e-02 | 9.43e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 9.24e-01 | -1.53e-02 | 9.57e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 85 | 8.08e-01 | -1.52e-02 | 8.91e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 30 | 8.85e-01 | 1.52e-02 | 9.37e-01 |
SUMOYLATION | 162 | 7.44e-01 | -1.49e-02 | 8.49e-01 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 9.35e-01 | 1.48e-02 | 9.60e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 9.10e-01 | -1.46e-02 | 9.48e-01 |
INTRA GOLGI TRAFFIC | 43 | 8.70e-01 | 1.44e-02 | 9.28e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 12 | 9.31e-01 | 1.43e-02 | 9.60e-01 |
MUSCLE CONTRACTION | 162 | 7.62e-01 | -1.38e-02 | 8.61e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 9.35e-01 | -1.36e-02 | 9.60e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 8.95e-01 | 1.33e-02 | 9.39e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 8.65e-01 | -1.27e-02 | 9.28e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 37 | 8.95e-01 | 1.26e-02 | 9.39e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 42 | 8.90e-01 | -1.24e-02 | 9.38e-01 |
HCMV LATE EVENTS | 64 | 8.67e-01 | 1.21e-02 | 9.28e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 12 | 9.42e-01 | 1.21e-02 | 9.63e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 9.30e-01 | -1.19e-02 | 9.60e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 9.39e-01 | 1.19e-02 | 9.61e-01 |
DEATH RECEPTOR SIGNALLING | 134 | 8.17e-01 | -1.16e-02 | 8.94e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 35 | 9.06e-01 | 1.15e-02 | 9.47e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 8.87e-01 | -1.09e-02 | 9.37e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 9.42e-01 | -1.08e-02 | 9.63e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 18 | 9.37e-01 | -1.07e-02 | 9.60e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 9.17e-01 | 1.07e-02 | 9.52e-01 |
G2 M DNA DAMAGE CHECKPOINT | 65 | 8.82e-01 | 1.06e-02 | 9.34e-01 |
SIGNALING BY SCF KIT | 41 | 9.08e-01 | 1.05e-02 | 9.47e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 8.80e-01 | 1.04e-02 | 9.34e-01 |
PRC2 METHYLATES HISTONES AND DNA | 29 | 9.30e-01 | -9.47e-03 | 9.60e-01 |
DAG AND IP3 SIGNALING | 40 | 9.18e-01 | -9.44e-03 | 9.52e-01 |
HYALURONAN METABOLISM | 15 | 9.52e-01 | 9.04e-03 | 9.70e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 28 | 9.34e-01 | -8.98e-03 | 9.60e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 9.01e-01 | 8.90e-03 | 9.43e-01 |
PD 1 SIGNALING | 10 | 9.62e-01 | -8.70e-03 | 9.76e-01 |
INTERFERON GAMMA SIGNALING | 73 | 9.01e-01 | 8.47e-03 | 9.43e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 9.36e-01 | -8.42e-03 | 9.60e-01 |
DNA DAMAGE BYPASS | 46 | 9.23e-01 | 8.20e-03 | 9.57e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 9.36e-01 | 7.99e-03 | 9.60e-01 |
ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 9.66e-01 | -7.85e-03 | 9.79e-01 |
FLT3 SIGNALING | 36 | 9.36e-01 | 7.71e-03 | 9.60e-01 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 9.60e-01 | -7.50e-03 | 9.76e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 9.58e-01 | -6.30e-03 | 9.75e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 9.70e-01 | 5.49e-03 | 9.82e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 9.34e-01 | 5.49e-03 | 9.60e-01 |
DEADENYLATION OF MRNA | 25 | 9.62e-01 | -5.47e-03 | 9.76e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 9.46e-01 | -5.28e-03 | 9.65e-01 |
ION HOMEOSTASIS | 48 | 9.53e-01 | 4.94e-03 | 9.70e-01 |
NEURONAL SYSTEM | 363 | 8.75e-01 | -4.80e-03 | 9.32e-01 |
L1CAM INTERACTIONS | 109 | 9.32e-01 | 4.77e-03 | 9.60e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 338 | 8.90e-01 | 4.39e-03 | 9.38e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 9.77e-01 | 4.37e-03 | 9.85e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1083 | 8.15e-01 | 4.25e-03 | 8.93e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 9.75e-01 | -4.09e-03 | 9.85e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 9.83e-01 | 3.20e-03 | 9.88e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 9.76e-01 | 3.13e-03 | 9.85e-01 |
INTERFERON SIGNALING | 160 | 9.47e-01 | -3.06e-03 | 9.66e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 9.79e-01 | 2.86e-03 | 9.86e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 9.83e-01 | -2.64e-03 | 9.88e-01 |
MET PROMOTES CELL MOTILITY | 39 | 9.78e-01 | 2.61e-03 | 9.85e-01 |
VXPX CARGO TARGETING TO CILIUM | 19 | 9.86e-01 | -2.36e-03 | 9.89e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 9.80e-01 | 2.23e-03 | 9.86e-01 |
PI METABOLISM | 79 | 9.77e-01 | 1.85e-03 | 9.85e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 100 | 9.76e-01 | -1.74e-03 | 9.85e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 9.92e-01 | 1.55e-03 | 9.93e-01 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 20 | 9.92e-01 | 1.36e-03 | 9.93e-01 |
MISMATCH REPAIR | 14 | 9.95e-01 | -1.05e-03 | 9.95e-01 |
FLT3 SIGNALING IN DISEASE | 27 | 1.00e+00 | 1.34e-05 | 1.00e+00 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
1096 | |
---|---|
set | TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR |
setSize | 11 |
pANOVA | 0.000176 |
s.dist | 0.653 |
p.adjustANOVA | 0.00166 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ctss | 7951 |
Lgmn | 7925 |
Ctsb | 7844 |
Tlr7 | 7102 |
Hsp90b1 | 6318 |
Unc93b1 | 5764 |
Ctsl | 5477 |
Tlr3 | 4653 |
Ctsk | 4393 |
Cnpy3 | 1652 |
Tlr9 | -1435 |
GeneID | Gene Rank |
---|---|
Ctss | 7951 |
Lgmn | 7925 |
Ctsb | 7844 |
Tlr7 | 7102 |
Hsp90b1 | 6318 |
Unc93b1 | 5764 |
Ctsl | 5477 |
Tlr3 | 4653 |
Ctsk | 4393 |
Cnpy3 | 1652 |
Tlr9 | -1435 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
656 | |
---|---|
set | NUCLEOTIDE LIKE PURINERGIC RECEPTORS |
setSize | 13 |
pANOVA | 0.000535 |
s.dist | 0.555 |
p.adjustANOVA | 0.00439 |
Top enriched genes
GeneID | Gene Rank |
---|---|
P2ry12 | 7413 |
P2ry1 | 7377 |
Adora3 | 7105 |
P2ry14 | 7091 |
P2ry13 | 5908 |
Gpr17 | 5849 |
Adora2b | 5032 |
Adora2a | 4708 |
P2ry6 | 3719 |
Lpar4 | 2292 |
Adora1 | 931 |
Lpar6 | 569 |
P2ry2 | -495 |
GeneID | Gene Rank |
---|---|
P2ry12 | 7413 |
P2ry1 | 7377 |
Adora3 | 7105 |
P2ry14 | 7091 |
P2ry13 | 5908 |
Gpr17 | 5849 |
Adora2b | 5032 |
Adora2a | 4708 |
P2ry6 | 3719 |
Lpar4 | 2292 |
Adora1 | 931 |
Lpar6 | 569 |
P2ry2 | -495 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
39 | |
---|---|
set | ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 |
setSize | 19 |
pANOVA | 4.07e-05 |
s.dist | 0.544 |
p.adjustANOVA | 0.00051 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng12 | 7806 |
P2ry12 | 7413 |
Gng10 | 7124 |
Gng5 | 7046 |
Gnai3 | 7033 |
Gnb5 | 6692 |
Gng11 | 6628 |
Gng7 | 5129 |
Gnai1 | 5064 |
Gng3 | 4233 |
Gnai2 | 4102 |
Gngt2 | 2842 |
Gnb4 | 2642 |
Gng8 | 2077 |
Gng4 | 2019 |
Gng2 | 1559 |
Gnb2 | 1365 |
Gng13 | 921 |
Gnb1 | 594 |
GeneID | Gene Rank |
---|---|
Gng12 | 7806 |
P2ry12 | 7413 |
Gng10 | 7124 |
Gng5 | 7046 |
Gnai3 | 7033 |
Gnb5 | 6692 |
Gng11 | 6628 |
Gng7 | 5129 |
Gnai1 | 5064 |
Gng3 | 4233 |
Gnai2 | 4102 |
Gngt2 | 2842 |
Gnb4 | 2642 |
Gng8 | 2077 |
Gng4 | 2019 |
Gng2 | 1559 |
Gnb2 | 1365 |
Gng13 | 921 |
Gnb1 | 594 |
ASPARTATE AND ASPARAGINE METABOLISM
72 | |
---|---|
set | ASPARTATE AND ASPARAGINE METABOLISM |
setSize | 10 |
pANOVA | 0.00302 |
s.dist | 0.542 |
p.adjustANOVA | 0.0172 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Asns | 7504 |
Slc25a13 | 7183 |
Folh1 | 6671 |
Got1 | 6570 |
Got2 | 5979 |
Naalad2 | 5317 |
Aspa | 4957 |
Slc25a12 | 4529 |
Nat8l | 103 |
Aspg | -5663 |
GeneID | Gene Rank |
---|---|
Asns | 7504 |
Slc25a13 | 7183 |
Folh1 | 6671 |
Got1 | 6570 |
Got2 | 5979 |
Naalad2 | 5317 |
Aspa | 4957 |
Slc25a12 | 4529 |
Nat8l | 103 |
Aspg | -5663 |
COMPLEX I BIOGENESIS
170 | |
---|---|
set | COMPLEX I BIOGENESIS |
setSize | 56 |
pANOVA | 4.2e-12 |
s.dist | 0.535 |
p.adjustANOVA | 2.88e-10 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ndufb5 | 7944 |
Ndufv2 | 7897 |
Ndufc1 | 7879 |
Ndufaf4 | 7875 |
mt-Nd4 | 7791 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
Ndufa10 | 7480 |
mt-Nd2 | 7440 |
Timmdc1 | 7361 |
Ndufaf1 | 7140 |
Ndufa5 | 7111 |
Ndufb9 | 6752 |
Ndufaf6 | 6597 |
Ndufb4 | 6558 |
GeneID | Gene Rank |
---|---|
Ndufb5 | 7944 |
Ndufv2 | 7897 |
Ndufc1 | 7879 |
Ndufaf4 | 7875 |
mt-Nd4 | 7791 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
Ndufa10 | 7480 |
mt-Nd2 | 7440 |
Timmdc1 | 7361 |
Ndufaf1 | 7140 |
Ndufa5 | 7111 |
Ndufb9 | 6752 |
Ndufaf6 | 6597 |
Ndufb4 | 6558 |
Ndufb11 | 6478 |
Ndufs1 | 6380 |
Ndufaf2 | 6187 |
Ndufb8 | 6186 |
Ndufs3 | 6000 |
Ndufa13 | 5845 |
Ndufaf5 | 5684 |
Ndufab1 | 5620 |
Ndufc2 | 4815 |
Ndufa6 | 4771 |
Ndufs5 | 4712 |
Ndufa7 | 4534 |
Ndufb6 | 4184 |
Ndufs6 | 3839 |
Ndufv1 | 3473 |
Ndufb1 | 3424 |
Tmem126b | 3234 |
Ndufa1 | 2822 |
Ndufb3 | 2499 |
Ecsit | 2347 |
Ndufs7 | 2105 |
Acad9 | 1990 |
Ndufa8 | 1700 |
Ndufb7 | 1370 |
Ndufb2 | 1235 |
Ndufs8 | 350 |
Ndufb10 | 315 |
Ndufv3 | 202 |
Nubpl | 24 |
Ndufa3 | -187 |
Ndufa11 | -921 |
Ndufaf3 | -1144 |
Ndufa9 | -1155 |
Ndufaf7 | -1201 |
Ndufa2 | -1362 |
Tmem186 | -7244 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
1045 | |
---|---|
set | SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS |
setSize | 20 |
pANOVA | 3.51e-05 |
s.dist | 0.534 |
p.adjustANOVA | 0.000455 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elovl1 | 8118 |
Hsd17b12 | 7866 |
Elovl5 | 7774 |
Hacd3 | 7769 |
Acsbg1 | 7556 |
Acsl3 | 7541 |
Hacd1 | 7417 |
Hacd2 | 7201 |
Elovl4 | 6855 |
Acsl4 | 5771 |
Elovl2 | 5586 |
Tecr | 4330 |
Acsl1 | 4281 |
Elovl7 | 3641 |
Acsl6 | 3624 |
Elovl6 | 1439 |
Hacd4 | -253 |
Acsl5 | -955 |
Slc27a3 | -5087 |
Acsf3 | -5411 |
GeneID | Gene Rank |
---|---|
Elovl1 | 8118 |
Hsd17b12 | 7866 |
Elovl5 | 7774 |
Hacd3 | 7769 |
Acsbg1 | 7556 |
Acsl3 | 7541 |
Hacd1 | 7417 |
Hacd2 | 7201 |
Elovl4 | 6855 |
Acsl4 | 5771 |
Elovl2 | 5586 |
Tecr | 4330 |
Acsl1 | 4281 |
Elovl7 | 3641 |
Acsl6 | 3624 |
Elovl6 | 1439 |
Hacd4 | -253 |
Acsl5 | -955 |
Slc27a3 | -5087 |
Acsf3 | -5411 |
TRIGLYCERIDE CATABOLISM
1137 | |
---|---|
set | TRIGLYCERIDE CATABOLISM |
setSize | 14 |
pANOVA | 0.000668 |
s.dist | 0.525 |
p.adjustANOVA | 0.00532 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Plin3 | 7871 |
Ppp1cc | 7074 |
Abhd5 | 7016 |
Ppp1cb | 6637 |
Prkacb | 6521 |
Fabp5 | 6248 |
Lipe | 4718 |
Ppp1ca | 4208 |
Gpd2 | 3444 |
Fabp3 | 1587 |
Mgll | 871 |
Prkaca | 1 |
Fabp7 | -5738 |
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Plin3 | 7871 |
Ppp1cc | 7074 |
Abhd5 | 7016 |
Ppp1cb | 6637 |
Prkacb | 6521 |
Fabp5 | 6248 |
Lipe | 4718 |
Ppp1ca | 4208 |
Gpd2 | 3444 |
Fabp3 | 1587 |
Mgll | 871 |
Prkaca | 1 |
Fabp7 | -5738 |
PINK1 PRKN MEDIATED MITOPHAGY
704 | |
---|---|
set | PINK1 PRKN MEDIATED MITOPHAGY |
setSize | 22 |
pANOVA | 2.44e-05 |
s.dist | 0.52 |
p.adjustANOVA | 0.000335 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tomm20 | 7698 |
Tomm6 | 6887 |
Atg5 | 6462 |
Rps27a | 6287 |
Map1lc3b | 5969 |
Vdac1 | 5870 |
Tomm22 | 5805 |
Pink1 | 5610 |
Tomm70a | 5588 |
Sqstm1 | 5432 |
Atg12 | 4934 |
Uba52 | 4679 |
Ubb | 4462 |
Map1lc3a | 4291 |
Mterf3 | 4096 |
Prkn | 4076 |
Tomm7 | 2400 |
Tomm5 | 1993 |
Tomm40 | 1049 |
Mfn2 | -565 |
GeneID | Gene Rank |
---|---|
Tomm20 | 7698 |
Tomm6 | 6887 |
Atg5 | 6462 |
Rps27a | 6287 |
Map1lc3b | 5969 |
Vdac1 | 5870 |
Tomm22 | 5805 |
Pink1 | 5610 |
Tomm70a | 5588 |
Sqstm1 | 5432 |
Atg12 | 4934 |
Uba52 | 4679 |
Ubb | 4462 |
Map1lc3a | 4291 |
Mterf3 | 4096 |
Prkn | 4076 |
Tomm7 | 2400 |
Tomm5 | 1993 |
Tomm40 | 1049 |
Mfn2 | -565 |
Ubc | -674 |
Mfn1 | -1475 |
FRS MEDIATED FGFR4 SIGNALING
344 | |
---|---|
set | FRS MEDIATED FGFR4 SIGNALING |
setSize | 12 |
pANOVA | 0.00192 |
s.dist | 0.517 |
p.adjustANOVA | 0.0122 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Frs2 | 4435 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Frs3 | 2469 |
Grb2 | 1153 |
Sos1 | 677 |
GeneID | Gene Rank |
---|---|
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Frs2 | 4435 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Frs3 | 2469 |
Grb2 | 1153 |
Sos1 | 677 |
SHC MEDIATED CASCADE FGFR4
921 | |
---|---|
set | SHC MEDIATED CASCADE FGFR4 |
setSize | 10 |
pANOVA | 0.00474 |
s.dist | 0.516 |
p.adjustANOVA | 0.0244 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Shc1 | 2132 |
Grb2 | 1153 |
Sos1 | 677 |
GeneID | Gene Rank |
---|---|
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Shc1 | 2132 |
Grb2 | 1153 |
Sos1 | 677 |
EUKARYOTIC TRANSLATION ELONGATION
302 | |
---|---|
set | EUKARYOTIC TRANSLATION ELONGATION |
setSize | 87 |
pANOVA | 1.06e-16 |
s.dist | 0.514 |
p.adjustANOVA | 1.12e-14 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Rps27l | 7476 |
Eef1g | 7474 |
Rps8 | 7351 |
Rps3a1 | 7090 |
Eef1a1 | 7063 |
Rpl22l1 | 6945 |
Rps23 | 6815 |
Eef1a2 | 6782 |
Rpl6 | 6753 |
Rps4x | 6720 |
Rpl23 | 6522 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Rpl37a | 6189 |
Rpl4 | 6147 |
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Rps27l | 7476 |
Eef1g | 7474 |
Rps8 | 7351 |
Rps3a1 | 7090 |
Eef1a1 | 7063 |
Rpl22l1 | 6945 |
Rps23 | 6815 |
Eef1a2 | 6782 |
Rpl6 | 6753 |
Rps4x | 6720 |
Rpl23 | 6522 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Rpl37a | 6189 |
Rpl4 | 6147 |
Rpl13a | 6123 |
Rpl5 | 6038 |
Rpl3 | 5935 |
Rplp0 | 5890 |
Rpl22 | 5876 |
Rps29 | 5797 |
Fau | 5746 |
Rpl31 | 5692 |
Rpl17 | 5602 |
Rpl14 | 5533 |
Rps18 | 5494 |
Rpl35a | 5482 |
Eef1b2 | 5431 |
Rps20 | 5420 |
Rpl18a | 5350 |
Rps19 | 5329 |
Rpl11 | 5300 |
Eef2 | 5248 |
Rps26 | 5233 |
Rpl27 | 5209 |
Rpl30 | 5196 |
Rpl9 | 5140 |
Rpl7 | 5019 |
Rps5 | 4949 |
Rpl39 | 4872 |
Uba52 | 4679 |
Rpl32 | 4626 |
Rpl35 | 4264 |
Rpl36a | 4037 |
Rpl38 | 3999 |
Rps28 | 3895 |
Rpl29 | 3662 |
Rpl26 | 3633 |
Rpl19 | 3567 |
Rps11 | 3518 |
Rpl34 | 3514 |
Eef1d | 3439 |
Rpl13 | 3236 |
Rps21 | 3188 |
Rpsa | 3113 |
Rpl15 | 3020 |
Rpl37 | 2953 |
Rpl27a | 2791 |
Rps17 | 2734 |
Rpl21 | 2678 |
Rpl8 | 2675 |
Rpl7a | 2288 |
Rps27 | 2204 |
Rps13 | 2150 |
Rps6 | 2046 |
Rps16 | 1905 |
Rpl36al | 1812 |
Rps2 | 1413 |
Rps3 | 1378 |
Rps10 | 1099 |
Rpl28 | 833 |
Rplp2 | 775 |
Rpl10a | 728 |
Rps15 | 684 |
Rpl18 | 262 |
Rps15a | -368 |
Rpl36 | -379 |
Rps12 | -530 |
Rplp1 | -556 |
Rps14 | -1429 |
Rpl10 | -3715 |
Rpl12 | -7475 |
CRMPS IN SEMA3A SIGNALING
188 | |
---|---|
set | CRMPS IN SEMA3A SIGNALING |
setSize | 16 |
pANOVA | 0.000387 |
s.dist | -0.512 |
p.adjustANOVA | 0.00332 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Plxna4 | -7942 |
Plxna3 | -7852 |
Plxna1 | -7441 |
Dpysl2 | -7160 |
Crmp1 | -6316 |
Dpysl4 | -6204 |
Dpysl3 | -5932 |
Dpysl5 | -5623 |
Plxna2 | -4399 |
Cdk5 | -4320 |
Nrp1 | -3883 |
Cdk5r1 | -2371 |
Gsk3b | -1843 |
Fes | -725 |
Fyn | 236 |
Sema3a | 873 |
GeneID | Gene Rank |
---|---|
Plxna4 | -7942 |
Plxna3 | -7852 |
Plxna1 | -7441 |
Dpysl2 | -7160 |
Crmp1 | -6316 |
Dpysl4 | -6204 |
Dpysl3 | -5932 |
Dpysl5 | -5623 |
Plxna2 | -4399 |
Cdk5 | -4320 |
Nrp1 | -3883 |
Cdk5r1 | -2371 |
Gsk3b | -1843 |
Fes | -725 |
Fyn | 236 |
Sema3a | 873 |
RESPIRATORY ELECTRON TRANSPORT
831 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT |
setSize | 102 |
pANOVA | 4.5e-19 |
s.dist | 0.511 |
p.adjustANOVA | 8.75e-17 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Coq10b | 8017 |
Ndufb5 | 7944 |
Ndufv2 | 7897 |
Ndufc1 | 7879 |
mt-Co1 | 7877 |
Ndufaf4 | 7875 |
mt-Nd4 | 7791 |
Cox7a2l | 7766 |
Sdhc | 7740 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
mt-Co2 | 7495 |
Ndufa10 | 7480 |
mt-Nd2 | 7440 |
mt-Cytb | 7410 |
GeneID | Gene Rank |
---|---|
Coq10b | 8017 |
Ndufb5 | 7944 |
Ndufv2 | 7897 |
Ndufc1 | 7879 |
mt-Co1 | 7877 |
Ndufaf4 | 7875 |
mt-Nd4 | 7791 |
Cox7a2l | 7766 |
Sdhc | 7740 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
mt-Co2 | 7495 |
Ndufa10 | 7480 |
mt-Nd2 | 7440 |
mt-Cytb | 7410 |
Timmdc1 | 7361 |
Cycs | 7344 |
Uqcrb | 7297 |
mt-Co3 | 7283 |
Ndufaf1 | 7140 |
Ndufa5 | 7111 |
Cox5a | 7096 |
Surf1 | 7002 |
Ndufa4 | 6926 |
Ndufb9 | 6752 |
Ndufaf6 | 6597 |
Ndufb4 | 6558 |
Cox6a1 | 6525 |
Ndufb11 | 6478 |
Ndufs1 | 6380 |
Ndufaf2 | 6187 |
Ndufb8 | 6186 |
Sco2 | 6002 |
Ndufs3 | 6000 |
Ndufa13 | 5845 |
Cox7c | 5828 |
Ndufaf5 | 5684 |
Ndufab1 | 5620 |
Uqcrc2 | 5490 |
Coq10a | 5363 |
Cox20 | 5321 |
Cox5b | 5286 |
Sdha | 5219 |
Sdhd | 5008 |
Taco1 | 4975 |
Cox6c | 4919 |
Ndufc2 | 4815 |
Ndufa6 | 4771 |
Cox16 | 4725 |
Ndufs5 | 4712 |
Cox8a | 4557 |
Ndufa7 | 4534 |
Cox7b | 4523 |
Sdhb | 4460 |
Uqcrq | 4400 |
Cox18 | 4186 |
Ndufb6 | 4184 |
Uqcrfs1 | 3896 |
Ndufs6 | 3839 |
Ndufv1 | 3473 |
Ndufb1 | 3424 |
Uqcrh | 3303 |
Tmem126b | 3234 |
Etfa | 3125 |
Ndufa1 | 2822 |
Ndufb3 | 2499 |
Ecsit | 2347 |
Cyc1 | 2327 |
Ndufs7 | 2105 |
Etfb | 2001 |
Acad9 | 1990 |
Cox6b1 | 1748 |
Ndufa8 | 1700 |
Ndufb7 | 1370 |
Ndufb2 | 1235 |
Etfdh | 1105 |
Uqcr10 | 944 |
Uqcrc1 | 825 |
Cox4i1 | 421 |
Ndufs8 | 350 |
Ndufb10 | 315 |
Ndufv3 | 202 |
Sco1 | 89 |
Nubpl | 24 |
Ndufa3 | -187 |
Trap1 | -275 |
Uqcr11 | -884 |
Ndufa11 | -921 |
Ndufaf3 | -1144 |
Ndufa9 | -1155 |
Ndufaf7 | -1201 |
Ndufa2 | -1362 |
Cox14 | -2274 |
Cox19 | -4424 |
Lrpprc | -6913 |
Cox11 | -7075 |
Tmem186 | -7244 |
CITRIC ACID CYCLE TCA CYCLE
153 | |
---|---|
set | CITRIC ACID CYCLE TCA CYCLE |
setSize | 22 |
pANOVA | 3.54e-05 |
s.dist | 0.509 |
p.adjustANOVA | 0.000455 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Idh3a | 7890 |
Sdhc | 7740 |
Suclg2 | 7068 |
Sucla2 | 6894 |
Nnt | 6565 |
Idh2 | 6267 |
Suclg1 | 5310 |
Sdha | 5219 |
Fh1 | 5176 |
Sdhd | 5008 |
Cs | 4980 |
Dld | 4601 |
Sdhb | 4460 |
Aco2 | 4210 |
Ogdh | 3795 |
Mdh2 | 3695 |
Me2 | 3460 |
Fahd1 | 1568 |
Me3 | 55 |
Dlst | -353 |
GeneID | Gene Rank |
---|---|
Idh3a | 7890 |
Sdhc | 7740 |
Suclg2 | 7068 |
Sucla2 | 6894 |
Nnt | 6565 |
Idh2 | 6267 |
Suclg1 | 5310 |
Sdha | 5219 |
Fh1 | 5176 |
Sdhd | 5008 |
Cs | 4980 |
Dld | 4601 |
Sdhb | 4460 |
Aco2 | 4210 |
Ogdh | 3795 |
Mdh2 | 3695 |
Me2 | 3460 |
Fahd1 | 1568 |
Me3 | 55 |
Dlst | -353 |
Idh3g | -2178 |
Idh3b | -2457 |
PI 3K CASCADE FGFR4
700 | |
---|---|
set | PI 3K CASCADE FGFR4 |
setSize | 10 |
pANOVA | 0.00534 |
s.dist | 0.509 |
p.adjustANOVA | 0.0265 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gab1 | 7496 |
Fgf1 | 7466 |
Pik3ca | 6278 |
Fgf2 | 5927 |
Frs2 | 4435 |
Fgf9 | 4376 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Grb2 | 1153 |
Pik3r1 | -3938 |
GeneID | Gene Rank |
---|---|
Gab1 | 7496 |
Fgf1 | 7466 |
Pik3ca | 6278 |
Fgf2 | 5927 |
Frs2 | 4435 |
Fgf9 | 4376 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Grb2 | 1153 |
Pik3r1 | -3938 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
832 | |
---|---|
set | RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS |
setSize | 125 |
pANOVA | 2.14e-22 |
s.dist | 0.504 |
p.adjustANOVA | 5e-20 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Coq10b | 8017 |
Ndufb5 | 7944 |
Atp5b | 7926 |
Ndufv2 | 7897 |
Ndufc1 | 7879 |
mt-Co1 | 7877 |
Ndufaf4 | 7875 |
Atp5a1 | 7859 |
mt-Nd4 | 7791 |
Cox7a2l | 7766 |
Sdhc | 7740 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
Atp5c1 | 7595 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
mt-Co2 | 7495 |
GeneID | Gene Rank |
---|---|
Coq10b | 8017 |
Ndufb5 | 7944 |
Atp5b | 7926 |
Ndufv2 | 7897 |
Ndufc1 | 7879 |
mt-Co1 | 7877 |
Ndufaf4 | 7875 |
Atp5a1 | 7859 |
mt-Nd4 | 7791 |
Cox7a2l | 7766 |
Sdhc | 7740 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
Atp5c1 | 7595 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
mt-Co2 | 7495 |
Ndufa10 | 7480 |
mt-Nd2 | 7440 |
mt-Cytb | 7410 |
Timmdc1 | 7361 |
Cycs | 7344 |
Uqcrb | 7297 |
mt-Co3 | 7283 |
Atp5pb | 7221 |
Ndufaf1 | 7140 |
Ndufa5 | 7111 |
Cox5a | 7096 |
Surf1 | 7002 |
Ndufa4 | 6926 |
Slc25a14 | 6823 |
Ndufb9 | 6752 |
Ucp2 | 6710 |
Ndufaf6 | 6597 |
Ndufb4 | 6558 |
mt-Atp6 | 6538 |
Cox6a1 | 6525 |
Ndufb11 | 6478 |
mt-Atp8 | 6392 |
Ndufs1 | 6380 |
Ndufaf2 | 6187 |
Ndufb8 | 6186 |
Atp5h | 6054 |
Sco2 | 6002 |
Ndufs3 | 6000 |
Ndufa13 | 5845 |
Cox7c | 5828 |
Ndufaf5 | 5684 |
Ndufab1 | 5620 |
Uqcrc2 | 5490 |
Coq10a | 5363 |
Cox20 | 5321 |
Cox5b | 5286 |
Sdha | 5219 |
Sdhd | 5008 |
Taco1 | 4975 |
Cox6c | 4919 |
Ndufc2 | 4815 |
Ndufa6 | 4771 |
Pm20d1 | 4760 |
Cox16 | 4725 |
Ndufs5 | 4712 |
Cox8a | 4557 |
Ndufa7 | 4534 |
Cox7b | 4523 |
Sdhb | 4460 |
Uqcrq | 4400 |
Atp5g3 | 4195 |
Cox18 | 4186 |
Ndufb6 | 4184 |
Ucp3 | 4013 |
Atp5o | 3980 |
Uqcrfs1 | 3896 |
Ndufs6 | 3839 |
Atp5j | 3778 |
Ndufv1 | 3473 |
Ndufb1 | 3424 |
Uqcrh | 3303 |
Tmem126b | 3234 |
Etfa | 3125 |
Ndufa1 | 2822 |
Dmac2l | 2813 |
Ndufb3 | 2499 |
Ecsit | 2347 |
Cyc1 | 2327 |
Ndufs7 | 2105 |
Etfb | 2001 |
Acad9 | 1990 |
Atp5d | 1771 |
Cox6b1 | 1748 |
Atp5l | 1715 |
Ndufa8 | 1700 |
Atp5j2 | 1380 |
Ndufb7 | 1370 |
Atp5e | 1326 |
Ndufb2 | 1235 |
Etfdh | 1105 |
Atp5g1 | 1065 |
Uqcr10 | 944 |
Uqcrc1 | 825 |
Cox4i1 | 421 |
Atp5k | 361 |
Ndufs8 | 350 |
Ndufb10 | 315 |
Ndufv3 | 202 |
Sco1 | 89 |
Nubpl | 24 |
Ndufa3 | -187 |
Trap1 | -275 |
Uqcr11 | -884 |
Ndufa11 | -921 |
Ndufaf3 | -1144 |
Ndufa9 | -1155 |
Ndufaf7 | -1201 |
Ndufa2 | -1362 |
Cox14 | -2274 |
Atp5g2 | -3018 |
Cox19 | -4424 |
Slc25a27 | -6531 |
Lrpprc | -6913 |
Cox11 | -7075 |
Tmem186 | -7244 |
PLATELET SENSITIZATION BY LDL
718 | |
---|---|
set | PLATELET SENSITIZATION BY LDL |
setSize | 15 |
pANOVA | 0.000766 |
s.dist | 0.502 |
p.adjustANOVA | 0.0058 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp2cb | 7900 |
Ppp2r5a | 7827 |
Ppp2r5b | 7715 |
Pla2g4a | 7167 |
Pecam1 | 6291 |
Ppp2r5c | 6221 |
Ppp2r5d | 6074 |
Ppp2ca | 6007 |
Ppp2r5e | 5885 |
Ppp2r1a | 5784 |
Ptpn6 | 5291 |
Ptpn11 | 3576 |
Ppp2r1b | -3518 |
Mapk14 | -4076 |
Lrp8 | -8388 |
GeneID | Gene Rank |
---|---|
Ppp2cb | 7900 |
Ppp2r5a | 7827 |
Ppp2r5b | 7715 |
Pla2g4a | 7167 |
Pecam1 | 6291 |
Ppp2r5c | 6221 |
Ppp2r5d | 6074 |
Ppp2ca | 6007 |
Ppp2r5e | 5885 |
Ppp2r1a | 5784 |
Ptpn6 | 5291 |
Ptpn11 | 3576 |
Ppp2r1b | -3518 |
Mapk14 | -4076 |
Lrp8 | -8388 |
FRS MEDIATED FGFR3 SIGNALING
343 | |
---|---|
set | FRS MEDIATED FGFR3 SIGNALING |
setSize | 14 |
pANOVA | 0.00121 |
s.dist | 0.5 |
p.adjustANOVA | 0.00822 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Frs2 | 4435 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Frs3 | 2469 |
Grb2 | 1153 |
Sos1 | 677 |
Fgf5 | -1717 |
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Frs2 | 4435 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Frs3 | 2469 |
Grb2 | 1153 |
Sos1 | 677 |
Fgf5 | -1717 |
SIGNALING BY FGFR3 FUSIONS IN CANCER
950 | |
---|---|
set | SIGNALING BY FGFR3 FUSIONS IN CANCER |
setSize | 10 |
pANOVA | 0.00628 |
s.dist | 0.499 |
p.adjustANOVA | 0.0303 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Gab1 | 7496 |
Pik3ca | 6278 |
Hras | 6143 |
Kras | 5612 |
Frs2 | 4435 |
Nras | 3869 |
Grb2 | 1153 |
Sos1 | 677 |
Pik3r1 | -3938 |
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Gab1 | 7496 |
Pik3ca | 6278 |
Hras | 6143 |
Kras | 5612 |
Frs2 | 4435 |
Nras | 3869 |
Grb2 | 1153 |
Sos1 | 677 |
Pik3r1 | -3938 |
SHC MEDIATED CASCADE FGFR3
920 | |
---|---|
set | SHC MEDIATED CASCADE FGFR3 |
setSize | 12 |
pANOVA | 0.00296 |
s.dist | 0.496 |
p.adjustANOVA | 0.0169 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Shc1 | 2132 |
Grb2 | 1153 |
Sos1 | 677 |
Fgf5 | -1717 |
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Fgf1 | 7466 |
Hras | 6143 |
Fgf2 | 5927 |
Kras | 5612 |
Fgf9 | 4376 |
Nras | 3869 |
Fgf18 | 3657 |
Shc1 | 2132 |
Grb2 | 1153 |
Sos1 | 677 |
Fgf5 | -1717 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
1028 | |
---|---|
set | SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES |
setSize | 29 |
pANOVA | 4.08e-06 |
s.dist | 0.494 |
p.adjustANOVA | 8.5e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ube2r2 | 8020 |
Ube2g1 | 7707 |
Ube2l3 | 7106 |
Ube2a | 6534 |
Rps27a | 6287 |
Ube2d2a | 6130 |
Ube2d1 | 5982 |
Ube2e3 | 5806 |
Otulin | 5552 |
Ube2e1 | 5415 |
Ube2q2 | 5320 |
Ube2w | 5304 |
Ube2b | 5258 |
Usp9x | 4842 |
Uba52 | 4679 |
Uba6 | 4674 |
Ubb | 4462 |
Ube2z | 4172 |
Cdc34 | 3659 |
Uchl3 | 3250 |
GeneID | Gene Rank |
---|---|
Ube2r2 | 8020 |
Ube2g1 | 7707 |
Ube2l3 | 7106 |
Ube2a | 6534 |
Rps27a | 6287 |
Ube2d2a | 6130 |
Ube2d1 | 5982 |
Ube2e3 | 5806 |
Otulin | 5552 |
Ube2e1 | 5415 |
Ube2q2 | 5320 |
Ube2w | 5304 |
Ube2b | 5258 |
Usp9x | 4842 |
Uba52 | 4679 |
Uba6 | 4674 |
Ubb | 4462 |
Ube2z | 4172 |
Cdc34 | 3659 |
Uchl3 | 3250 |
Ube2h | 2615 |
Usp5 | 2451 |
Ube2k | 2135 |
Ube2s | 840 |
Uba1 | 320 |
Ubc | -674 |
Ube2t | -678 |
Usp7 | -1723 |
Ube2g2 | -1824 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS
101 | |
---|---|
set | BLOOD GROUP SYSTEMS BIOSYNTHESIS |
setSize | 13 |
pANOVA | 0.00206 |
s.dist | 0.494 |
p.adjustANOVA | 0.0129 |
Top enriched genes
GeneID | Gene Rank |
---|---|
St3gal4 | 8093 |
B3galt5 | 6528 |
B3galt2 | 6470 |
St3gal6 | 5385 |
B3galt1 | 5293 |
Fut9 | 5234 |
Fut11 | 4673 |
Fut10 | 3978 |
St6galnac6 | 3150 |
Fut2 | 2113 |
St3gal3 | 1139 |
Fut4 | 841 |
B3galt4 | -1984 |
GeneID | Gene Rank |
---|---|
St3gal4 | 8093 |
B3galt5 | 6528 |
B3galt2 | 6470 |
St3gal6 | 5385 |
B3galt1 | 5293 |
Fut9 | 5234 |
Fut11 | 4673 |
Fut10 | 3978 |
St6galnac6 | 3150 |
Fut2 | 2113 |
St3gal3 | 1139 |
Fut4 | 841 |
B3galt4 | -1984 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
1005 | |
---|---|
set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
setSize | 106 |
pANOVA | 2.77e-18 |
s.dist | 0.49 |
p.adjustANOVA | 3.59e-16 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Spcs1 | 7967 |
Rps25 | 7858 |
Rps9 | 7627 |
Ssr3 | 7589 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Rps27l | 7476 |
Rps8 | 7351 |
Srp72 | 7263 |
Rps3a1 | 7090 |
Srp54a | 7056 |
Rpl22l1 | 6945 |
Sec11c | 6816 |
Rps23 | 6815 |
Rpl6 | 6753 |
Rps4x | 6720 |
Srpr | 6582 |
Rpl23 | 6522 |
Rps24 | 6391 |
Rps7 | 6301 |
GeneID | Gene Rank |
---|---|
Spcs1 | 7967 |
Rps25 | 7858 |
Rps9 | 7627 |
Ssr3 | 7589 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Rps27l | 7476 |
Rps8 | 7351 |
Srp72 | 7263 |
Rps3a1 | 7090 |
Srp54a | 7056 |
Rpl22l1 | 6945 |
Sec11c | 6816 |
Rps23 | 6815 |
Rpl6 | 6753 |
Rps4x | 6720 |
Srpr | 6582 |
Rpl23 | 6522 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Rpl37a | 6189 |
Rpl4 | 6147 |
Rpl13a | 6123 |
Ddost | 6104 |
Spcs3 | 6039 |
Rpl5 | 6038 |
Rpl3 | 5935 |
Rplp0 | 5890 |
Rpl22 | 5876 |
Rps29 | 5797 |
Fau | 5746 |
Rpl31 | 5692 |
Srp9 | 5648 |
Rpl17 | 5602 |
Rpl14 | 5533 |
Rps18 | 5494 |
Rpl35a | 5482 |
Spcs2 | 5471 |
Srprb | 5458 |
Rps20 | 5420 |
Rpl18a | 5350 |
Rps19 | 5329 |
Rpl11 | 5300 |
Rps26 | 5233 |
Rpl27 | 5209 |
Rpl30 | 5196 |
Rpl9 | 5140 |
Ssr1 | 5034 |
Rpl7 | 5019 |
Rps5 | 4949 |
Rpl39 | 4872 |
Uba52 | 4679 |
Rpl32 | 4626 |
Rpl35 | 4264 |
Srp19 | 4114 |
Ssr2 | 4052 |
Rpl36a | 4037 |
Rpl38 | 3999 |
Rps28 | 3895 |
Srp14 | 3836 |
Rpl29 | 3662 |
Rpl26 | 3633 |
Rpl19 | 3567 |
Rps11 | 3518 |
Rpl34 | 3514 |
Rpn2 | 3270 |
Rpl13 | 3236 |
Sec61g | 3229 |
Rps21 | 3188 |
Rpsa | 3113 |
Rpl15 | 3020 |
Rpl37 | 2953 |
Rpl27a | 2791 |
Rps17 | 2734 |
Rpl21 | 2678 |
Rpl8 | 2675 |
Rpn1 | 2597 |
Tram1 | 2538 |
Rpl7a | 2288 |
Rps27 | 2204 |
Rps13 | 2150 |
Sec61b | 2098 |
Rps6 | 2046 |
Rps16 | 1905 |
Rpl36al | 1812 |
Rps2 | 1413 |
Rps3 | 1378 |
Rps10 | 1099 |
Rpl28 | 833 |
Sec11a | 819 |
Rplp2 | 775 |
Rpl10a | 728 |
Rps15 | 684 |
Rpl18 | 262 |
Ssr4 | -81 |
Rps15a | -368 |
Rpl36 | -379 |
Rps12 | -530 |
Rplp1 | -556 |
Srp68 | -977 |
Rps14 | -1429 |
Rpl10 | -3715 |
Sec61a1 | -5469 |
Sec61a2 | -6158 |
Rpl12 | -7475 |
PI 3K CASCADE FGFR3
699 | |
---|---|
set | PI 3K CASCADE FGFR3 |
setSize | 12 |
pANOVA | 0.00331 |
s.dist | 0.49 |
p.adjustANOVA | 0.0182 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Gab1 | 7496 |
Fgf1 | 7466 |
Pik3ca | 6278 |
Fgf2 | 5927 |
Frs2 | 4435 |
Fgf9 | 4376 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Grb2 | 1153 |
Fgf5 | -1717 |
Pik3r1 | -3938 |
GeneID | Gene Rank |
---|---|
Fgfr3 | 7898 |
Gab1 | 7496 |
Fgf1 | 7466 |
Pik3ca | 6278 |
Fgf2 | 5927 |
Frs2 | 4435 |
Fgf9 | 4376 |
Fgf18 | 3657 |
Ptpn11 | 3576 |
Grb2 | 1153 |
Fgf5 | -1717 |
Pik3r1 | -3938 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS
1116 | |
---|---|
set | TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS |
setSize | 15 |
pANOVA | 0.00113 |
s.dist | 0.486 |
p.adjustANOVA | 0.00783 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sox2 | 7746 |
Smad4 | 6985 |
Hhex | 6617 |
Hif3a | 6505 |
Sall1 | 6354 |
Klf4 | 5974 |
Fgf2 | 5927 |
Epas1 | 3990 |
Stat3 | 3875 |
Tsc22d1 | 3290 |
Smad2 | 3119 |
Foxp1 | 2381 |
Pbx1 | 579 |
Zic3 | 417 |
Nr6a1 | -6007 |
GeneID | Gene Rank |
---|---|
Sox2 | 7746 |
Smad4 | 6985 |
Hhex | 6617 |
Hif3a | 6505 |
Sall1 | 6354 |
Klf4 | 5974 |
Fgf2 | 5927 |
Epas1 | 3990 |
Stat3 | 3875 |
Tsc22d1 | 3290 |
Smad2 | 3119 |
Foxp1 | 2381 |
Pbx1 | 579 |
Zic3 | 417 |
Nr6a1 | -6007 |
RHOBTB3 ATPASE CYCLE
856 | |
---|---|
set | RHOBTB3 ATPASE CYCLE |
setSize | 10 |
pANOVA | 0.00805 |
s.dist | 0.484 |
p.adjustANOVA | 0.037 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Plin3 | 7871 |
Rhobtb3 | 7502 |
Cul3 | 7450 |
Rab9 | 6893 |
Vhl | 5231 |
Rab9b | 4732 |
Lrrc41 | 2739 |
Htr7 | 2253 |
Hgs | 613 |
Ccne1 | -6917 |
GeneID | Gene Rank |
---|---|
Plin3 | 7871 |
Rhobtb3 | 7502 |
Cul3 | 7450 |
Rab9 | 6893 |
Vhl | 5231 |
Rab9b | 4732 |
Lrrc41 | 2739 |
Htr7 | 2253 |
Hgs | 613 |
Ccne1 | -6917 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
326 | |
---|---|
set | FORMATION OF ATP BY CHEMIOSMOTIC COUPLING |
setSize | 18 |
pANOVA | 0.000384 |
s.dist | 0.483 |
p.adjustANOVA | 0.00332 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5b | 7926 |
Atp5a1 | 7859 |
Atp5c1 | 7595 |
Atp5pb | 7221 |
mt-Atp6 | 6538 |
mt-Atp8 | 6392 |
Atp5h | 6054 |
Atp5g3 | 4195 |
Atp5o | 3980 |
Atp5j | 3778 |
Dmac2l | 2813 |
Atp5d | 1771 |
Atp5l | 1715 |
Atp5j2 | 1380 |
Atp5e | 1326 |
Atp5g1 | 1065 |
Atp5k | 361 |
Atp5g2 | -3018 |
GeneID | Gene Rank |
---|---|
Atp5b | 7926 |
Atp5a1 | 7859 |
Atp5c1 | 7595 |
Atp5pb | 7221 |
mt-Atp6 | 6538 |
mt-Atp8 | 6392 |
Atp5h | 6054 |
Atp5g3 | 4195 |
Atp5o | 3980 |
Atp5j | 3778 |
Dmac2l | 2813 |
Atp5d | 1771 |
Atp5l | 1715 |
Atp5j2 | 1380 |
Atp5e | 1326 |
Atp5g1 | 1065 |
Atp5k | 361 |
Atp5g2 | -3018 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
27 | |
---|---|
set | ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S |
setSize | 59 |
pANOVA | 1.91e-10 |
s.dist | 0.479 |
p.adjustANOVA | 1.01e-08 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rps27l | 7476 |
Eif2s2 | 7384 |
Eif2s1 | 7376 |
Rps8 | 7351 |
Eif3j2 | 7325 |
Eif2s3x | 7320 |
Rps3a1 | 7090 |
Eif3e | 6908 |
Eif3m | 6834 |
Rps23 | 6815 |
Rps4x | 6720 |
Eif4e | 6693 |
Pabpc1 | 6473 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Eif4a2 | 5815 |
Rps29 | 5797 |
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rps27l | 7476 |
Eif2s2 | 7384 |
Eif2s1 | 7376 |
Rps8 | 7351 |
Eif3j2 | 7325 |
Eif2s3x | 7320 |
Rps3a1 | 7090 |
Eif3e | 6908 |
Eif3m | 6834 |
Rps23 | 6815 |
Rps4x | 6720 |
Eif4e | 6693 |
Pabpc1 | 6473 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Eif4a2 | 5815 |
Rps29 | 5797 |
Eif3f | 5750 |
Fau | 5746 |
Rps18 | 5494 |
Rps20 | 5420 |
Eif3h | 5368 |
Rps19 | 5329 |
Rps26 | 5233 |
Rps5 | 4949 |
Eif4b | 4222 |
Eif3g | 4201 |
Rps28 | 3895 |
Eif1ax | 3743 |
Eif3l | 3734 |
Rps11 | 3518 |
Rps21 | 3188 |
Eif4ebp1 | 3184 |
Rpsa | 3113 |
Eif3c | 2740 |
Rps17 | 2734 |
Eif3i | 2278 |
Eif4a1 | 2227 |
Rps27 | 2204 |
Rps13 | 2150 |
Rps6 | 2046 |
Rps16 | 1905 |
Eif3b | 1735 |
Rps2 | 1413 |
Rps3 | 1378 |
Rps10 | 1099 |
Rps15 | 684 |
Eif3j1 | 347 |
Eif3d | 142 |
Rps15a | -368 |
Rps12 | -530 |
Eif4h | -1077 |
Eif3k | -1122 |
Rps14 | -1429 |
Eif3a | -4675 |
Eif4g1 | -6404 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
81 | |
---|---|
set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES |
setSize | 10 |
pANOVA | 0.00908 |
s.dist | 0.476 |
p.adjustANOVA | 0.0411 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Xbp1 | 7923 |
Calr | 7910 |
Hspa5 | 7749 |
Nfyc | 6772 |
Hsp90b1 | 6318 |
Nfyb | 4927 |
Ddit3 | 4261 |
Atf6 | 1166 |
Atf4 | -2106 |
Nfya | -7169 |
GeneID | Gene Rank |
---|---|
Xbp1 | 7923 |
Calr | 7910 |
Hspa5 | 7749 |
Nfyc | 6772 |
Hsp90b1 | 6318 |
Nfyb | 4927 |
Ddit3 | 4261 |
Atf6 | 1166 |
Atf4 | -2106 |
Nfya | -7169 |
FATTY ACYL COA BIOSYNTHESIS
311 | |
---|---|
set | FATTY ACYL COA BIOSYNTHESIS |
setSize | 32 |
pANOVA | 3.15e-06 |
s.dist | 0.476 |
p.adjustANOVA | 6.8e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elovl1 | 8118 |
Scd2 | 8076 |
Scd1 | 7997 |
Hsd17b12 | 7866 |
Elovl5 | 7774 |
Hacd3 | 7769 |
Acsbg1 | 7556 |
Acsl3 | 7541 |
Hacd1 | 7417 |
Hacd2 | 7201 |
Elovl4 | 6855 |
Ppt1 | 6205 |
Slc25a1 | 6125 |
Acsl4 | 5771 |
Elovl2 | 5586 |
Tecr | 4330 |
Acsl1 | 4281 |
Acly | 3707 |
Elovl7 | 3641 |
Acsl6 | 3624 |
GeneID | Gene Rank |
---|---|
Elovl1 | 8118 |
Scd2 | 8076 |
Scd1 | 7997 |
Hsd17b12 | 7866 |
Elovl5 | 7774 |
Hacd3 | 7769 |
Acsbg1 | 7556 |
Acsl3 | 7541 |
Hacd1 | 7417 |
Hacd2 | 7201 |
Elovl4 | 6855 |
Ppt1 | 6205 |
Slc25a1 | 6125 |
Acsl4 | 5771 |
Elovl2 | 5586 |
Tecr | 4330 |
Acsl1 | 4281 |
Acly | 3707 |
Elovl7 | 3641 |
Acsl6 | 3624 |
Cbr4 | 3571 |
Rpp14 | 3562 |
H2-Ke6 | 2048 |
Elovl6 | 1439 |
Fasn | 1074 |
Ppt2 | 712 |
Acaca | 149 |
Hacd4 | -253 |
Acsl5 | -955 |
Slc27a3 | -5087 |
Acsf3 | -5411 |
Morc2a | -7767 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES
337 | |
---|---|
set | FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES |
setSize | 17 |
pANOVA | 0.000716 |
s.dist | 0.474 |
p.adjustANOVA | 0.00557 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Btg1 | 8014 |
Smad4 | 6985 |
Mstn | 6803 |
Cdkn1b | 6120 |
Klf4 | 5974 |
Ccng2 | 5735 |
Rbl2 | 5403 |
Foxg1 | 5259 |
Foxo1 | 4366 |
Smad3 | 3892 |
Smad2 | 3119 |
Pcbp4 | 3011 |
Foxo3 | 1080 |
Gadd45a | -2055 |
Foxo4 | -3211 |
Cdkn1a | -4735 |
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Btg1 | 8014 |
Smad4 | 6985 |
Mstn | 6803 |
Cdkn1b | 6120 |
Klf4 | 5974 |
Ccng2 | 5735 |
Rbl2 | 5403 |
Foxg1 | 5259 |
Foxo1 | 4366 |
Smad3 | 3892 |
Smad2 | 3119 |
Pcbp4 | 3011 |
Foxo3 | 1080 |
Gadd45a | -2055 |
Foxo4 | -3211 |
Cdkn1a | -4735 |
EUKARYOTIC TRANSLATION INITIATION
303 | |
---|---|
set | EUKARYOTIC TRANSLATION INITIATION |
setSize | 114 |
pANOVA | 2.33e-18 |
s.dist | 0.474 |
p.adjustANOVA | 3.4e-16 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Rps27l | 7476 |
Eif2s2 | 7384 |
Eif2s1 | 7376 |
Rps8 | 7351 |
Eif3j2 | 7325 |
Eif2s3x | 7320 |
Rps3a1 | 7090 |
Rpl22l1 | 6945 |
Eif3e | 6908 |
Eif3m | 6834 |
Rps23 | 6815 |
Rpl6 | 6753 |
Rps4x | 6720 |
Eif4e | 6693 |
Rpl23 | 6522 |
Pabpc1 | 6473 |
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Rps27l | 7476 |
Eif2s2 | 7384 |
Eif2s1 | 7376 |
Rps8 | 7351 |
Eif3j2 | 7325 |
Eif2s3x | 7320 |
Rps3a1 | 7090 |
Rpl22l1 | 6945 |
Eif3e | 6908 |
Eif3m | 6834 |
Rps23 | 6815 |
Rpl6 | 6753 |
Rps4x | 6720 |
Eif4e | 6693 |
Rpl23 | 6522 |
Pabpc1 | 6473 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Rpl37a | 6189 |
Rpl4 | 6147 |
Rpl13a | 6123 |
Rpl5 | 6038 |
Rpl3 | 5935 |
Rplp0 | 5890 |
Rpl22 | 5876 |
Eif4a2 | 5815 |
Rps29 | 5797 |
Eif3f | 5750 |
Fau | 5746 |
Rpl31 | 5692 |
Rpl17 | 5602 |
Rpl14 | 5533 |
Rps18 | 5494 |
Rpl35a | 5482 |
Eif5b | 5446 |
Rps20 | 5420 |
Eif3h | 5368 |
Rpl18a | 5350 |
Rps19 | 5329 |
Rpl11 | 5300 |
Rps26 | 5233 |
Rpl27 | 5209 |
Rpl30 | 5196 |
Rpl9 | 5140 |
Rpl7 | 5019 |
Rps5 | 4949 |
Eif5 | 4917 |
Rpl39 | 4872 |
Uba52 | 4679 |
Rpl32 | 4626 |
Eif2b2 | 4507 |
Rpl35 | 4264 |
Eif4b | 4222 |
Eif3g | 4201 |
Rpl36a | 4037 |
Rpl38 | 3999 |
Rps28 | 3895 |
Eif1ax | 3743 |
Eif3l | 3734 |
Rpl29 | 3662 |
Rpl26 | 3633 |
Rpl19 | 3567 |
Rps11 | 3518 |
Rpl34 | 3514 |
Eif2b5 | 3325 |
Rpl13 | 3236 |
Rps21 | 3188 |
Eif4ebp1 | 3184 |
Rpsa | 3113 |
Rpl15 | 3020 |
Eif2b4 | 3006 |
Rpl37 | 2953 |
Rpl27a | 2791 |
Eif3c | 2740 |
Rps17 | 2734 |
Rpl21 | 2678 |
Rpl8 | 2675 |
Rpl7a | 2288 |
Eif3i | 2278 |
Eif4a1 | 2227 |
Rps27 | 2204 |
Rps13 | 2150 |
Rps6 | 2046 |
Rps16 | 1905 |
Rpl36al | 1812 |
Eif3b | 1735 |
Rps2 | 1413 |
Rps3 | 1378 |
Rps10 | 1099 |
Rpl28 | 833 |
Rplp2 | 775 |
Rpl10a | 728 |
Rps15 | 684 |
Eif3j1 | 347 |
Rpl18 | 262 |
Eif3d | 142 |
Rps15a | -368 |
Rpl36 | -379 |
Rps12 | -530 |
Rplp1 | -556 |
Eif4h | -1077 |
Eif3k | -1122 |
Eif2b3 | -1343 |
Rps14 | -1429 |
Eif2b1 | -2155 |
Rpl10 | -3715 |
Eif3a | -4675 |
Eif4g1 | -6404 |
Rpl12 | -7475 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR
746 | |
---|---|
set | PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR |
setSize | 16 |
pANOVA | 0.00105 |
s.dist | 0.473 |
p.adjustANOVA | 0.0075 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng12 | 7806 |
Gng10 | 7124 |
Gng5 | 7046 |
Gnb5 | 6692 |
Gng11 | 6628 |
Gng7 | 5129 |
Gng3 | 4233 |
Gngt2 | 2842 |
Gnb4 | 2642 |
Gng8 | 2077 |
Gng4 | 2019 |
Gng2 | 1559 |
Gnb2 | 1365 |
Gnas | 1269 |
Gng13 | 921 |
Gnb1 | 594 |
GeneID | Gene Rank |
---|---|
Gng12 | 7806 |
Gng10 | 7124 |
Gng5 | 7046 |
Gnb5 | 6692 |
Gng11 | 6628 |
Gng7 | 5129 |
Gng3 | 4233 |
Gngt2 | 2842 |
Gnb4 | 2642 |
Gng8 | 2077 |
Gng4 | 2019 |
Gng2 | 1559 |
Gnb2 | 1365 |
Gnas | 1269 |
Gng13 | 921 |
Gnb1 | 594 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
45 | |
---|---|
set | ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM |
setSize | 12 |
pANOVA | 0.00471 |
s.dist | 0.471 |
p.adjustANOVA | 0.0243 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elovl1 | 8118 |
Elovl5 | 7774 |
Scp2 | 7637 |
Hsd17b4 | 7396 |
Elovl2 | 5586 |
Acox1 | 5292 |
Fads2 | 4736 |
Acsl1 | 4281 |
Fads1 | 4276 |
Acot8 | -1056 |
Abcd1 | -2475 |
Acaa1a | -6796 |
GeneID | Gene Rank |
---|---|
Elovl1 | 8118 |
Elovl5 | 7774 |
Scp2 | 7637 |
Hsd17b4 | 7396 |
Elovl2 | 5586 |
Acox1 | 5292 |
Fads2 | 4736 |
Acsl1 | 4281 |
Fads1 | 4276 |
Acot8 | -1056 |
Abcd1 | -2475 |
Acaa1a | -6796 |
RAS PROCESSING
774 | |
---|---|
set | RAS PROCESSING |
setSize | 23 |
pANOVA | 9.45e-05 |
s.dist | 0.47 |
p.adjustANOVA | 0.000989 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Abhd17b | 7891 |
Abhd17c | 7874 |
Golga7 | 7400 |
Fnta | 7322 |
Zdhhc9 | 6874 |
Bcl2l1 | 6711 |
Rps27a | 6287 |
Hras | 6143 |
Lypla1 | 5859 |
Kras | 5612 |
Pde6d | 5591 |
Calm1 | 5542 |
Uba52 | 4679 |
Ubb | 4462 |
Abhd17a | 4110 |
Nras | 3869 |
Prkcq | 3124 |
Prkg2 | 2320 |
Ubc | -674 |
Fntb | -1258 |
GeneID | Gene Rank |
---|---|
Abhd17b | 7891 |
Abhd17c | 7874 |
Golga7 | 7400 |
Fnta | 7322 |
Zdhhc9 | 6874 |
Bcl2l1 | 6711 |
Rps27a | 6287 |
Hras | 6143 |
Lypla1 | 5859 |
Kras | 5612 |
Pde6d | 5591 |
Calm1 | 5542 |
Uba52 | 4679 |
Ubb | 4462 |
Abhd17a | 4110 |
Nras | 3869 |
Prkcq | 3124 |
Prkg2 | 2320 |
Ubc | -674 |
Fntb | -1258 |
Arl2 | -2069 |
Rce1 | -4926 |
Icmt | -7173 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT
1060 | |
---|---|
set | THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT |
setSize | 172 |
pANOVA | 2.15e-26 |
s.dist | 0.47 |
p.adjustANOVA | 8.35e-24 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Coq10b | 8017 |
Pdk3 | 7973 |
Ndufb5 | 7944 |
Atp5b | 7926 |
Ndufv2 | 7897 |
Idh3a | 7890 |
Ndufc1 | 7879 |
mt-Co1 | 7877 |
Ndufaf4 | 7875 |
Atp5a1 | 7859 |
mt-Nd4 | 7791 |
Cox7a2l | 7766 |
Sdhc | 7740 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
Dlat | 7600 |
Atp5c1 | 7595 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
GeneID | Gene Rank |
---|---|
Coq10b | 8017 |
Pdk3 | 7973 |
Ndufb5 | 7944 |
Atp5b | 7926 |
Ndufv2 | 7897 |
Idh3a | 7890 |
Ndufc1 | 7879 |
mt-Co1 | 7877 |
Ndufaf4 | 7875 |
Atp5a1 | 7859 |
mt-Nd4 | 7791 |
Cox7a2l | 7766 |
Sdhc | 7740 |
mt-Nd3 | 7696 |
mt-Nd6 | 7692 |
Dlat | 7600 |
Atp5c1 | 7595 |
mt-Nd1 | 7590 |
Ndufa12 | 7566 |
Ndufs4 | 7517 |
Ndufs2 | 7516 |
mt-Nd5 | 7514 |
mt-Co2 | 7495 |
Ndufa10 | 7480 |
mt-Nd2 | 7440 |
mt-Cytb | 7410 |
Timmdc1 | 7361 |
Cycs | 7344 |
Uqcrb | 7297 |
mt-Co3 | 7283 |
Pdha1 | 7264 |
Atp5pb | 7221 |
Mpc1 | 7215 |
Ndufaf1 | 7140 |
Ndufa5 | 7111 |
Cox5a | 7096 |
Suclg2 | 7068 |
Surf1 | 7002 |
Ndufa4 | 6926 |
Sucla2 | 6894 |
Slc25a14 | 6823 |
Ndufb9 | 6752 |
Glo1 | 6716 |
Ucp2 | 6710 |
Ndufaf6 | 6597 |
Nnt | 6565 |
Ndufb4 | 6558 |
mt-Atp6 | 6538 |
Cox6a1 | 6525 |
Ndufb11 | 6478 |
mt-Atp8 | 6392 |
Ndufs1 | 6380 |
Rxra | 6289 |
Idh2 | 6267 |
Ndufaf2 | 6187 |
Ndufb8 | 6186 |
Atp5h | 6054 |
Sco2 | 6002 |
Ndufs3 | 6000 |
Pdk4 | 5986 |
Ldhb | 5921 |
Vdac1 | 5870 |
Ndufa13 | 5845 |
Pdp1 | 5830 |
Cox7c | 5828 |
Me1 | 5757 |
Ndufaf5 | 5684 |
Ndufab1 | 5620 |
Uqcrc2 | 5490 |
Coq10a | 5363 |
Mpc2 | 5346 |
Cox20 | 5321 |
Suclg1 | 5310 |
Cox5b | 5286 |
Sdha | 5219 |
Fh1 | 5176 |
Pdhb | 5141 |
Sdhd | 5008 |
Cs | 4980 |
Taco1 | 4975 |
Cox6c | 4919 |
Pdhx | 4836 |
Ndufc2 | 4815 |
Ndufa6 | 4771 |
Pm20d1 | 4760 |
Cox16 | 4725 |
Ndufs5 | 4712 |
Dld | 4601 |
Cox8a | 4557 |
Ndufa7 | 4534 |
Cox7b | 4523 |
Adhfe1 | 4469 |
Sdhb | 4460 |
Uqcrq | 4400 |
Aco2 | 4210 |
Atp5g3 | 4195 |
Cox18 | 4186 |
Ndufb6 | 4184 |
Slc16a1 | 4038 |
Ucp3 | 4013 |
Atp5o | 3980 |
Uqcrfs1 | 3896 |
Ndufs6 | 3839 |
Ogdh | 3795 |
Atp5j | 3778 |
Mdh2 | 3695 |
Ndufv1 | 3473 |
Me2 | 3460 |
Ndufb1 | 3424 |
Bsg | 3344 |
Uqcrh | 3303 |
Ppard | 3261 |
Tmem126b | 3234 |
Etfa | 3125 |
Ndufa1 | 2822 |
Dmac2l | 2813 |
Ndufb3 | 2499 |
Ecsit | 2347 |
Cyc1 | 2327 |
Ndufs7 | 2105 |
Etfb | 2001 |
Acad9 | 1990 |
Atp5d | 1771 |
Cox6b1 | 1748 |
Atp5l | 1715 |
Ndufa8 | 1700 |
Hagh | 1628 |
Fahd1 | 1568 |
Atp5j2 | 1380 |
Ndufb7 | 1370 |
Atp5e | 1326 |
Ndufb2 | 1235 |
Etfdh | 1105 |
Atp5g1 | 1065 |
Uqcr10 | 944 |
Uqcrc1 | 825 |
Cox4i1 | 421 |
Atp5k | 361 |
Ndufs8 | 350 |
Pdk2 | 329 |
Ndufb10 | 315 |
Ndufv3 | 202 |
Sco1 | 89 |
Me3 | 55 |
Nubpl | 24 |
Ldha | -113 |
Ndufa3 | -187 |
Trap1 | -275 |
Dlst | -353 |
Uqcr11 | -884 |
Ndufa11 | -921 |
Ndufaf3 | -1144 |
D2hgdh | -1145 |
Ndufa9 | -1155 |
Ndufaf7 | -1201 |
Ndufa2 | -1362 |
L2hgdh | -1916 |
Slc16a3 | -1977 |
Idh3g | -2178 |
Cox14 | -2274 |
Idh3b | -2457 |
Pdpr | -2918 |
Atp5g2 | -3018 |
Gstz1 | -4290 |
Cox19 | -4424 |
Slc25a27 | -6531 |
Lrpprc | -6913 |
Pdp2 | -6928 |
Cox11 | -7075 |
Tmem186 | -7244 |
Slc16a8 | -7493 |
Pdk1 | -8282 |
GLYCOGEN SYNTHESIS
387 | |
---|---|
set | GLYCOGEN SYNTHESIS |
setSize | 14 |
pANOVA | 0.00242 |
s.dist | 0.468 |
p.adjustANOVA | 0.0145 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pgm1 | 8125 |
Ugp2 | 7604 |
Gbe1 | 7449 |
Gyg | 7282 |
Rps27a | 6287 |
Nhlrc1 | 5027 |
Ppp1r3c | 4989 |
Uba52 | 4679 |
Ubb | 4462 |
Gys1 | 3094 |
Pgm2 | 724 |
Pgm2l1 | -550 |
Ubc | -674 |
Epm2a | -6621 |
GeneID | Gene Rank |
---|---|
Pgm1 | 8125 |
Ugp2 | 7604 |
Gbe1 | 7449 |
Gyg | 7282 |
Rps27a | 6287 |
Nhlrc1 | 5027 |
Ppp1r3c | 4989 |
Uba52 | 4679 |
Ubb | 4462 |
Gys1 | 3094 |
Pgm2 | 724 |
Pgm2l1 | -550 |
Ubc | -674 |
Epm2a | -6621 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
834 | |
---|---|
set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
setSize | 94 |
pANOVA | 4.97e-15 |
s.dist | 0.467 |
p.adjustANOVA | 4.46e-13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Asns | 7504 |
Rps27l | 7476 |
Eif2s2 | 7384 |
Eif2s1 | 7376 |
Rps8 | 7351 |
Eif2s3x | 7320 |
Rps3a1 | 7090 |
Rpl22l1 | 6945 |
Rps23 | 6815 |
Rpl6 | 6753 |
Rps4x | 6720 |
Rpl23 | 6522 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Rpl37a | 6189 |
GeneID | Gene Rank |
---|---|
Rps25 | 7858 |
Rps9 | 7627 |
Rpl23a | 7569 |
Rpl24 | 7540 |
Asns | 7504 |
Rps27l | 7476 |
Eif2s2 | 7384 |
Eif2s1 | 7376 |
Rps8 | 7351 |
Eif2s3x | 7320 |
Rps3a1 | 7090 |
Rpl22l1 | 6945 |
Rps23 | 6815 |
Rpl6 | 6753 |
Rps4x | 6720 |
Rpl23 | 6522 |
Rps24 | 6391 |
Rps7 | 6301 |
Rps27a | 6287 |
Rpl37a | 6189 |
Rpl4 | 6147 |
Rpl13a | 6123 |
Rpl5 | 6038 |
Rpl3 | 5935 |
Rplp0 | 5890 |
Rpl22 | 5876 |
Rps29 | 5797 |
Fau | 5746 |
Rpl31 | 5692 |
Rpl17 | 5602 |
Impact | 5553 |
Rpl14 | 5533 |
Rps18 | 5494 |
Rpl35a | 5482 |
Rps20 | 5420 |
Rpl18a | 5350 |
Rps19 | 5329 |
Rpl11 | 5300 |
Rps26 | 5233 |
Rpl27 | 5209 |
Rpl30 | 5196 |
Rpl9 | 5140 |
Rpl7 | 5019 |
Rps5 | 4949 |
Rpl39 | 4872 |
Uba52 | 4679 |
Rpl32 | 4626 |
Cebpb | 4517 |
Rpl35 | 4264 |
Ddit3 | 4261 |
Rpl36a | 4037 |
Rpl38 | 3999 |
Rps28 | 3895 |
Rpl29 | 3662 |
Rpl26 | 3633 |
Rpl19 | 3567 |
Rps11 | 3518 |
Rpl34 | 3514 |
Rpl13 | 3236 |
Rps21 | 3188 |
Rpsa | 3113 |
Rpl15 | 3020 |
Rpl37 | 2953 |
Rpl27a | 2791 |
Rps17 | 2734 |
Rpl21 | 2678 |
Rpl8 | 2675 |
Rpl7a | 2288 |
Rps27 | 2204 |
Rps13 | 2150 |
Rps6 | 2046 |
Rps16 | 1905 |
Rpl36al | 1812 |
Atf2 | 1701 |
Rps2 | 1413 |
Rps3 | 1378 |
Rps10 | 1099 |
Rpl28 | 833 |
Rplp2 | 775 |
Rpl10a | 728 |
Rps15 | 684 |
Cebpg | 649 |
Rpl18 | 262 |
Rps15a | -368 |
Rpl36 | -379 |
Rps12 | -530 |
Rplp1 | -556 |
Atf3 | -1131 |
Rps14 | -1429 |
Atf4 | -2106 |
Rpl10 | -3715 |
Rpl12 | -7475 |
Gcn1 | -7718 |
Eif2ak4 | -8362 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION
547 | |
---|---|
set | METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION |
setSize | 15 |
pANOVA | 0.00197 |
s.dist | 0.462 |
p.adjustANOVA | 0.0124 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Ddah1 | 7708 |
Wasl | 7633 |
Cygb | 5958 |
Lypla1 | 5859 |
Hsp90aa1 | 5561 |
Calm1 | 5542 |
Nostrin | 5529 |
Ddah2 | 5412 |
Akt1 | 1895 |
Dnm2 | 1477 |
Nosip | 1160 |
Spr | 474 |
Nos3 | 164 |
Zdhhc21 | -7662 |
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Ddah1 | 7708 |
Wasl | 7633 |
Cygb | 5958 |
Lypla1 | 5859 |
Hsp90aa1 | 5561 |
Calm1 | 5542 |
Nostrin | 5529 |
Ddah2 | 5412 |
Akt1 | 1895 |
Dnm2 | 1477 |
Nosip | 1160 |
Spr | 474 |
Nos3 | 164 |
Zdhhc21 | -7662 |
G BETA GAMMA SIGNALLING THROUGH CDC42
350 | |
---|---|
set | G BETA GAMMA SIGNALLING THROUGH CDC42 |
setSize | 18 |
pANOVA | 0.000775 |
s.dist | 0.458 |
p.adjustANOVA | 0.0058 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gng12 | 7806 |
Gng10 | 7124 |
Gng5 | 7046 |
Gnb5 | 6692 |
Gng11 | 6628 |
Cdc42 | 6360 |
Gng7 | 5129 |
Pak1 | 4487 |
Gng3 | 4233 |
Gngt2 | 2842 |
Gnb4 | 2642 |
Gng8 | 2077 |
Gng4 | 2019 |
Gng2 | 1559 |
Gnb2 | 1365 |
Gng13 | 921 |
Gnb1 | 594 |
Arhgef6 | -4422 |
GeneID | Gene Rank |
---|---|
Gng12 | 7806 |
Gng10 | 7124 |
Gng5 | 7046 |
Gnb5 | 6692 |
Gng11 | 6628 |
Cdc42 | 6360 |
Gng7 | 5129 |
Pak1 | 4487 |
Gng3 | 4233 |
Gngt2 | 2842 |
Gnb4 | 2642 |
Gng8 | 2077 |
Gng4 | 2019 |
Gng2 | 1559 |
Gnb2 | 1365 |
Gng13 | 921 |
Gnb1 | 594 |
Arhgef6 | -4422 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS
541 | |
---|---|
set | METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS |
setSize | 10 |
pANOVA | 0.0123 |
s.dist | 0.457 |
p.adjustANOVA | 0.0523 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Agt | 7606 |
Ctsd | 7188 |
Atp6ap2 | 6697 |
Ctsz | 6129 |
Anpep | 6059 |
Ace2 | 5655 |
Ace | 4117 |
Mme | 3650 |
Enpep | -4525 |
Aopep | -6417 |
GeneID | Gene Rank |
---|---|
Agt | 7606 |
Ctsd | 7188 |
Atp6ap2 | 6697 |
Ctsz | 6129 |
Anpep | 6059 |
Ace2 | 5655 |
Ace | 4117 |
Mme | 3650 |
Enpep | -4525 |
Aopep | -6417 |
GLYCOGEN STORAGE DISEASES
386 | |
---|---|
set | GLYCOGEN STORAGE DISEASES |
setSize | 12 |
pANOVA | 0.00647 |
s.dist | 0.454 |
p.adjustANOVA | 0.0311 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gbe1 | 7449 |
Gyg | 7282 |
Rps27a | 6287 |
Nhlrc1 | 5027 |
Ppp1r3c | 4989 |
Uba52 | 4679 |
Ubb | 4462 |
Gaa | 3614 |
G6pc3 | 3464 |
Gys1 | 3094 |
Ubc | -674 |
Epm2a | -6621 |
GeneID | Gene Rank |
---|---|
Gbe1 | 7449 |
Gyg | 7282 |
Rps27a | 6287 |
Nhlrc1 | 5027 |
Ppp1r3c | 4989 |
Uba52 | 4679 |
Ubb | 4462 |
Gaa | 3614 |
G6pc3 | 3464 |
Gys1 | 3094 |
Ubc | -674 |
Epm2a | -6621 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT
158 | |
---|---|
set | CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT |
setSize | 20 |
pANOVA | 0.000442 |
s.dist | 0.454 |
p.adjustANOVA | 0.00368 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Slc25a17 | 8077 |
Pex2 | 7870 |
Atad1 | 7415 |
Abcd3 | 7379 |
Pex13 | 7006 |
Fis1 | 7005 |
Pex19 | 6866 |
Abcd2 | 6373 |
Gdap1 | 4773 |
Acbd5 | 4665 |
Pxmp2 | 3668 |
Aldh3a2 | 3588 |
Pex11b | 3172 |
Pex3 | 1834 |
Pex12 | 1617 |
Pxmp4 | 1131 |
Pex14 | -1275 |
Pex16 | -1370 |
Abcd1 | -2475 |
Pex26 | -5619 |
GeneID | Gene Rank |
---|---|
Slc25a17 | 8077 |
Pex2 | 7870 |
Atad1 | 7415 |
Abcd3 | 7379 |
Pex13 | 7006 |
Fis1 | 7005 |
Pex19 | 6866 |
Abcd2 | 6373 |
Gdap1 | 4773 |
Acbd5 | 4665 |
Pxmp2 | 3668 |
Aldh3a2 | 3588 |
Pex11b | 3172 |
Pex3 | 1834 |
Pex12 | 1617 |
Pxmp4 | 1131 |
Pex14 | -1275 |
Pex16 | -1370 |
Abcd1 | -2475 |
Pex26 | -5619 |
PROTEIN METHYLATION
749 | |
---|---|
set | PROTEIN METHYLATION |
setSize | 17 |
pANOVA | 0.00124 |
s.dist | 0.452 |
p.adjustANOVA | 0.00839 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Vcp | 7130 |
Eef1a1 | 7063 |
Camkmt | 5732 |
Kin | 5704 |
Calm1 | 5542 |
Hspa8 | 5342 |
Eef2 | 5248 |
Prmt3 | 5086 |
Eef1akmt1 | 4898 |
Eef1akmt2 | 3787 |
Mettl21a | 3585 |
Etfb | 2001 |
Rps2 | 1413 |
Mettl22 | 1306 |
Vcpkmt | 181 |
Etfbkmt | -988 |
Eef2kmt | -2295 |
GeneID | Gene Rank |
---|---|
Vcp | 7130 |
Eef1a1 | 7063 |
Camkmt | 5732 |
Kin | 5704 |
Calm1 | 5542 |
Hspa8 | 5342 |
Eef2 | 5248 |
Prmt3 | 5086 |
Eef1akmt1 | 4898 |
Eef1akmt2 | 3787 |
Mettl21a | 3585 |
Etfb | 2001 |
Rps2 | 1413 |
Mettl22 | 1306 |
Vcpkmt | 181 |
Etfbkmt | -988 |
Eef2kmt | -2295 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
1030 | |
---|---|
set | SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL |
setSize | 12 |
pANOVA | 0.00693 |
s.dist | 0.45 |
p.adjustANOVA | 0.0326 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Scp2 | 7637 |
Hsd3b7 | 7511 |
Hsd17b4 | 7396 |
Rxra | 6289 |
Ptgis | 6078 |
Cyp7b1 | 4727 |
Cyp27a1 | 4437 |
Slc27a2 | 2607 |
Amacr | 2242 |
Acot8 | -1056 |
Ncoa2 | -2259 |
Ncoa1 | -2932 |
GeneID | Gene Rank |
---|---|
Scp2 | 7637 |
Hsd3b7 | 7511 |
Hsd17b4 | 7396 |
Rxra | 6289 |
Ptgis | 6078 |
Cyp7b1 | 4727 |
Cyp27a1 | 4437 |
Slc27a2 | 2607 |
Amacr | 2242 |
Acot8 | -1056 |
Ncoa2 | -2259 |
Ncoa1 | -2932 |
ENOS ACTIVATION
283 | |
---|---|
set | ENOS ACTIVATION |
setSize | 11 |
pANOVA | 0.01 |
s.dist | 0.448 |
p.adjustANOVA | 0.0444 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Ddah1 | 7708 |
Cygb | 5958 |
Lypla1 | 5859 |
Hsp90aa1 | 5561 |
Calm1 | 5542 |
Ddah2 | 5412 |
Akt1 | 1895 |
Spr | 474 |
Nos3 | 164 |
Zdhhc21 | -7662 |
GeneID | Gene Rank |
---|---|
Cav1 | 8035 |
Ddah1 | 7708 |
Cygb | 5958 |
Lypla1 | 5859 |
Hsp90aa1 | 5561 |
Calm1 | 5542 |
Ddah2 | 5412 |
Akt1 | 1895 |
Spr | 474 |
Nos3 | 164 |
Zdhhc21 | -7662 |
DARPP 32 EVENTS
207 | |
---|---|
set | DARPP 32 EVENTS |
setSize | 23 |
pANOVA | 0.000228 |
s.dist | 0.444 |
p.adjustANOVA | 0.00208 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ppp2cb | 7900 |
Prkar2b | 6989 |
Ppp3r1 | 6923 |
Ppp3ca | 6774 |
Prkar2a | 6573 |
Prkacb | 6521 |
Ppp3cb | 6517 |
Prkar1a | 6081 |
Ppp2r5d | 6074 |
Ppp2ca | 6007 |
Ppp2r1a | 5784 |
Pde4b | 5604 |
Calm1 | 5542 |
Ppp1r1b | 5017 |
Ppp1ca | 4208 |
Prkar1b | 3052 |
Pde4c | 790 |
Prkaca | 1 |
Pde4a | -425 |
Ppp2r1b | -3518 |
GeneID | Gene Rank |
---|---|
Ppp2cb | 7900 |
Prkar2b | 6989 |
Ppp3r1 | 6923 |
Ppp3ca | 6774 |
Prkar2a | 6573 |
Prkacb | 6521 |
Ppp3cb | 6517 |
Prkar1a | 6081 |
Ppp2r5d | 6074 |
Ppp2ca | 6007 |
Ppp2r1a | 5784 |
Pde4b | 5604 |
Calm1 | 5542 |
Ppp1r1b | 5017 |
Ppp1ca | 4208 |
Prkar1b | 3052 |
Pde4c | 790 |
Prkaca | 1 |
Pde4a | -425 |
Ppp2r1b | -3518 |
Ppp3cc | -3740 |
Pde4d | -3800 |
Cdk5 | -4320 |
MITOPHAGY
570 | |
---|---|
set | MITOPHAGY |
setSize | 29 |
pANOVA | 5.75e-05 |
s.dist | 0.432 |
p.adjustANOVA | 0.000665 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tomm20 | 7698 |
Fundc1 | 7515 |
Tomm6 | 6887 |
Atg5 | 6462 |
Rps27a | 6287 |
Map1lc3b | 5969 |
Vdac1 | 5870 |
Tomm22 | 5805 |
Pink1 | 5610 |
Tomm70a | 5588 |
Sqstm1 | 5432 |
Csnk2a1 | 4960 |
Atg12 | 4934 |
Uba52 | 4679 |
Ubb | 4462 |
Map1lc3a | 4291 |
Mterf3 | 4096 |
Prkn | 4076 |
Csnk2b | 4024 |
Tomm7 | 2400 |
GeneID | Gene Rank |
---|---|
Tomm20 | 7698 |
Fundc1 | 7515 |
Tomm6 | 6887 |
Atg5 | 6462 |
Rps27a | 6287 |
Map1lc3b | 5969 |
Vdac1 | 5870 |
Tomm22 | 5805 |
Pink1 | 5610 |
Tomm70a | 5588 |
Sqstm1 | 5432 |
Csnk2a1 | 4960 |
Atg12 | 4934 |
Uba52 | 4679 |
Ubb | 4462 |
Map1lc3a | 4291 |
Mterf3 | 4096 |
Prkn | 4076 |
Csnk2b | 4024 |
Tomm7 | 2400 |
Pgam5 | 2302 |
Tomm5 | 1993 |
Tomm40 | 1049 |
Mfn2 | -565 |
Ubc | -674 |
Mfn1 | -1475 |
Csnk2a2 | -2246 |
Ulk1 | -3158 |
Src | -5723 |
CRISTAE FORMATION
187 | |
---|---|
set | CRISTAE FORMATION |
setSize | 31 |
pANOVA | 3.33e-05 |
s.dist | 0.431 |
p.adjustANOVA | 0.000446 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Atp5b | 7926 |
Atp5a1 | 7859 |
Atp5c1 | 7595 |
Immt | 7357 |
Atp5pb | 7221 |
Apoo | 6687 |
mt-Atp6 | 6538 |
mt-Atp8 | 6392 |
Chchd3 | 6319 |
Apool | 6095 |
Atp5h | 6054 |
Micos13 | 5290 |
Hspa9 | 4465 |
Atp5g3 | 4195 |
Atp5o | 3980 |
Atp5j | 3778 |
Mtx2 | 3332 |
Dmac2l | 2813 |
Atp5d | 1771 |
Atp5l | 1715 |
GeneID | Gene Rank |
---|---|
Atp5b | 7926 |
Atp5a1 | 7859 |
Atp5c1 | 7595 |
Immt | 7357 |
Atp5pb | 7221 |
Apoo | 6687 |
mt-Atp6 | 6538 |
mt-Atp8 | 6392 |
Chchd3 | 6319 |
Apool | 6095 |
Atp5h | 6054 |
Micos13 | 5290 |
Hspa9 | 4465 |
Atp5g3 | 4195 |
Atp5o | 3980 |
Atp5j | 3778 |
Mtx2 | 3332 |
Dmac2l | 2813 |
Atp5d | 1771 |
Atp5l | 1715 |
Atp5j2 | 1380 |
Atp5e | 1326 |
Atp5g1 | 1065 |
Micos10 | 1030 |
Tmem11 | 546 |
Atp5k | 361 |
Chchd6 | -14 |
Dnajc11 | -1025 |
Mtx1 | -1760 |
Samm50 | -2183 |
Atp5g2 | -3018 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX
1042 | |
---|---|
set | SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX |
setSize | 13 |
pANOVA | 0.0072 |
s.dist | 0.43 |
p.adjustANOVA | 0.0335 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptgds | 7968 |
Ptgr2 | 6513 |
Ptgis | 6078 |
Ptges3 | 5824 |
Ptgs1 | 5375 |
Hpgd | 4920 |
Hpgds | 4780 |
Ptges | 4713 |
Prxl2b | 4285 |
Ptges2 | 1260 |
Tbxas1 | 541 |
Ptgs2 | -3988 |
Cbr1 | -4165 |
GeneID | Gene Rank |
---|---|
Ptgds | 7968 |
Ptgr2 | 6513 |
Ptgis | 6078 |
Ptges3 | 5824 |
Ptgs1 | 5375 |
Hpgd | 4920 |
Hpgds | 4780 |
Ptges | 4713 |
Prxl2b | 4285 |
Ptges2 | 1260 |
Tbxas1 | 541 |
Ptgs2 | -3988 |
Cbr1 | -4165 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.1 (2023-06-16)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: /usr/share/zoneinfo/Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] GGally_2.1.2 gtools_3.9.4
## [3] echarts4r_0.4.5 beeswarm_0.4.0
## [5] pkgload_1.3.2.1 vioplot_0.4.0
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.16.0 limma_3.56.2
## [11] eulerr_7.0.0 mitch_1.12.0
## [13] MASS_7.3-60 fgsea_1.26.0
## [15] gplots_3.1.3 DESeq2_1.40.2
## [17] SummarizedExperiment_1.30.2 Biobase_2.60.0
## [19] MatrixGenerics_1.12.3 matrixStats_1.0.0
## [21] GenomicRanges_1.52.0 GenomeInfoDb_1.36.2
## [23] IRanges_2.34.1 S4Vectors_0.38.1
## [25] BiocGenerics_0.46.0 reshape2_1.4.4
## [27] lubridate_1.9.2 forcats_1.0.0
## [29] stringr_1.5.0 dplyr_1.1.2
## [31] purrr_1.0.2 readr_2.1.4
## [33] tidyr_1.3.0 tibble_3.2.1
## [35] ggplot2_3.4.3 tidyverse_2.0.0
## [37] zoo_1.8-12
##
## loaded via a namespace (and not attached):
## [1] bitops_1.0-7 gridExtra_2.3 rlang_1.1.1
## [4] magrittr_2.0.3 compiler_4.3.1 polylabelr_0.2.0
## [7] systemfonts_1.0.4 vctrs_0.6.3 rvest_1.0.3
## [10] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1
## [13] XVector_0.40.0 ellipsis_0.3.2 labeling_0.4.2
## [16] caTools_1.18.2 utf8_1.2.3 promises_1.2.1
## [19] rmarkdown_2.24 tzdb_0.4.0 xfun_0.40
## [22] zlibbioc_1.46.0 cachem_1.0.8 jsonlite_1.8.7
## [25] highr_0.10 later_1.3.1 DelayedArray_0.26.7
## [28] reshape_0.8.9 BiocParallel_1.34.2 parallel_4.3.1
## [31] R6_2.5.1 bslib_0.5.1 stringi_1.7.12
## [34] RColorBrewer_1.1-3 jquerylib_0.1.4 assertthat_0.2.1
## [37] Rcpp_1.0.11 knitr_1.43 httpuv_1.6.11
## [40] Matrix_1.6-1 timechange_0.2.0 tidyselect_1.2.0
## [43] rstudioapi_0.15.0 abind_1.4-5 yaml_2.3.7
## [46] codetools_0.2-19 lattice_0.21-8 plyr_1.8.8
## [49] shiny_1.7.5 withr_2.5.0 evaluate_0.21
## [52] polyclip_1.10-4 xml2_1.3.5 pillar_1.9.0
## [55] KernSmooth_2.23-22 generics_0.1.3 RCurl_1.98-1.12
## [58] hms_1.1.3 munsell_0.5.0 scales_1.2.1
## [61] xtable_1.8-4 glue_1.6.2 tools_4.3.1
## [64] data.table_1.14.8 webshot_0.5.5 locfit_1.5-9.8
## [67] fastmatch_1.1-4 cowplot_1.1.1 grid_4.3.1
## [70] colorspace_2.1-0 GenomeInfoDbData_1.2.10 cli_3.6.1
## [73] fansi_1.0.4 viridisLite_0.4.2 S4Arrays_1.0.5
## [76] svglite_2.1.1 gtable_0.3.4 sass_0.4.7
## [79] digest_0.6.33 farver_2.1.1 htmlwidgets_1.6.2
## [82] htmltools_0.5.6 lifecycle_1.0.3 httr_1.4.7
## [85] mime_0.12
END of report